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Semaphorins are secreted or transmembrane proteins implicated in various 
physiological processes such as axon guidance, cell motility and attachment, vascular 
growth, immune cell regulation, and tumour progression. Many of these functions are 
mediated through plexins, the main receptors for semaphorins. While accumulating 
evidence suggests the regulation of Rho family GTPases as the common signaling 
mechanisms mediated by different plexins upon semaphorin stimulation, the 
subtype-specific functions of each semaphorin/plexin interaction remains largely 
unknown. In this project, we characterized the role of plexin-B3 in oligodendrocyte 
development using an oligodendroglia cell line OLN-93 that endogenously expresses 
this molecule. Our studies revealed that OLN-93 migration is inhibited upon 
stimulation by Sema5A, the putative ligand of plexin-B3. Sema5A also promotes 
outgrowth and branching of cellular process of OLN-93, which is reminiscent of 
morphological differentiation and maturation of oligodendrocyte precursors. These 
effects were confirmed to be mediated through plexin-B3 by overexpression and 
dominant negative approaches. Analysis of the signaling pathways in OLN-93 cells 
upon Sema5A stimulation revealed that the RhoGTPase family member Cdc42 is 
activated, which is accompanied by a redistribution of CNPase to cell periphery and 
protrusions. These represent potential mechanisms underlying the induction of 
morphologic differentiation by Sema5A/plexin-B3 interaction. 
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CHAPTER 1 Introduction 
1.1 Axon guidance and guidance cues 
1.1.1 Axon guidance and Growth cone 
Precise wiring of distinct neuronal circuits in the nervous system is required for 
both brain development and functional recovery after brain injury and diseases in 
adult brain. Axon is a long slender process of neuron, which conducts electrical 
impulses away from the soma to other neurons. Axon guidance (also called axon 
pathfinding) is a critical event of neural development concerning the process by which 
neurons send out axons to reach the correct targets. These precise connections of the 
nervous system are established by directing axons to their specific targets by complex 
guidance systems. To direct them in the developing embryo, the growth cone, a 
sensory motile structure at the tip of axons, explores its surroundings, responds to 
guidance cues and steers the axon along a defined path to its appropriate target. 
Extracellular guidance cues，whose expression is controlled both temporally and 
spatially, can either attract or repel growth cones, and can operate either at close range 
or over a distance. Significant progress has been made in identifying the guidance 
molecules and receptors that regulate growth cone pathfinding, the signaling cascades 
underlying distinct growth cone behaviors, and the cytoskeletal components that give 
rise to the directional motility of growth cone. 
Growth cone turning is a complex process in which actin-based motility is 
harnessed to produce persistent and directed microtubule advance. Growth cone has 
three main regions: 1) a central core is rich in microtubule that forms stable, 
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cross-linked bundles; 2) projecting from the body are long slender extensions called 
filopodia containing dense, parallel filaments that radiate out; 3) between filopodia are 
lamellipodia, which are loosely intervening actin networks.  
The filopodia are the mechanism by which the entire process adheres to surfaces 
and explores the surrounding environment. Inhibition of filopodial extension leads to 
errors in pathfinding. Their membranes bear receptors for molecules that serve as 
directional cues for axon. When receptors in the filopodia encounter signals in the 
environment, the growth cone is stimulated to advance, retract, or turn. Lamellipodia 
are also motile and give growth cone its characteristic ruffled appearance.  
By comparison, the primary structural unit of an axon is the microtubule. Microtubule 
polymerization drives axonal outgrowth and is necessary for growth cone guidance. 
Axonal microtubules are characterized by stable dynamics and a highly aligned and 
tightly bundled morphology. Once microtubules enter the growth cone, the free ends 
splay outward and explore and retract in a much more dynamic fashion (Maskery and 
Shinbrot, 2005).  
Recent evidence revealed that in the process of axonal guidance, microtubule 
invasion along oriented actin bundles directs axonal outgrowth and that growth cone 
collapse is driven by actin depolymerization at the leading edge.  
 
1.1.2 Axon guidance molecules  
During development of the nervous system, axons are guided to their proper 
targets by sensing a variety of extracellular cues in the local environment. 
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Biochemical and genetic studies have revealed four major classes of axon guidance 
molecules, including the netrins, the slits, the semaphorins and the ephrins, which 
have been extensively studied (Barton et al., 2004; Chilton, 2006; Plachez and 
Richards, 2005). Guidance cues are expressed in various regions of the brain, and 
neurons expressing specific receptors recognize these cues and correctly project their 
axons to target cells according to the guiding map of guidance cues. Axon guidance 
cues are categorized into two groups, attractive and repulsive cues, based on the 
direction of response: axons move toward the source of attractive cues and avoid the 
source of repulsive cues. Netrins mainly serve as attractive guidance cues while slit 
and ephrins function to be repulsive cues. Although firstly identified to be repulsive 
cues, semaphorins have been shown to be bifunctional and can act as both axon 
attractants and repellants (Kantor et al., 2004) . Receptors for these guidance cues 
have also been identified, and DCC and UNC-5, robos, plexins and neuropilins, and 
Ephs are the receptors for netrins, slits, semaphorins and ephrins, respectively. 
 
 
1.2 Semaphorins and their receptors neuropilins and plexins  
Semaphorins were identified as molecular cues for axon guidance that are 
conserved from invertebrates to vertebrates. These proteins are now known to be 
involved in a variety of processes ranging from the guidance of cell migration, 
immune responses, to cancer (Chedotal et al., 2005; Neufeld et al., 2005). Plexins, 
either alone or in association with neuropilins, constitute functional semaphorin 
receptors to mediate the signaling of semaphorins. 
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1.2.1 Semaphorin/plexin families and their functions 
Semaphorins are secreted or membrane-associated glycoproteins that have been 
grouped into eight classes on the basis of their structural elements and amino acid 
sequence similarity (Tamagnone et al., 1999) (Fig. 1) . Class 1 and 2 semaphorins are 
found in invertebrates; class 3-7 are vertebrate semaphorins; and the final group is 
encoded by viruses. Semaphorin class 1, 4, 5, 6 are transmembrane molecules and 
class 7 is membrane-associated form through a glycosylphosphatidylinositol-anchor 
motif, whereas class 2 and 3 and the viral semaphorins are secreted. All semaphorins 
contain a conserved ~400 amino-acid sema domain. Furthermore, the extracellular 
domain of semaphorins is cysteine-rich and includes a conserved PSI (plexin, 
semaphorin, integrin) motif, which is also referred to as Met Related Sequence (MRS). 
C-terminal to the sema and PSI domains, a single immunoglobulin-like domain is 
found in semaphorin class 2, 3, 4 and 7 whereas class 5 semaphorins have seven 
thrombospondin domains. Of the transmembrane semaphorins, class 6 semaphorins 
have the largest intracellular domain containing proline-rich motifs. Class 4 
semaphorins have PDZ-binding domain at their C-termini of intracellular domain. 
The specific receptors for semaphorins are plexins. The plexins are a homogeneous 
family of transmembrane proteins which were first identified to be involved in cell 
adhesion (Ohta et al., 1995). Besides the two plexins found in invertebrate species, 
mammalian plexins are classified into four subfamilies on the basis of sequence 
homology: plexin-A1 to A4, plexin-B1 to B3, plexin-C1 and plexin-D1 (Tamagnone 
et al., 1999). All known plexins are characterized by a sema domain at the  
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Figure 1. Schematic illustration of plexins and their receptor specificity. 
Semaphorins and plexins are depicted. There are eight classes of semaphorins and 
four types of plexin. Sema, semaphorin; GAP, GTPase-activating protein; PSI, 
plexins, semaphorins and integrins; TSP, thrombospondin repeats; Ig, 
immunoglobulin; GPI, glycosyl phosphatidylinositol anchor; IPT, integrins, plexins 
and transcription factors; PDZ, PSD95/Discs Large/ZO-1. (Kruger et al., 2005) 
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N-terminus, which is mainly responsible for ligand interactions. Additionally, 
following the sema domain, plexins have three PSI domains and three IPT (Ig-like, 
plexins and transcription factors) domains in their extracellular domains. The 
cytoplasmic domain of plexins is large (~600 amino acid) and strikingly conserved 
among family members (57-90% similarity) and in evolution (>50% similarity 
between invertebrates and humans) (Maestrini et al., 1996). The plexin intracellular 
domain shares homology with the GAP domain of p120 RasGAP. This 
GAP-homology region is divided into two by a specific linker region, which in 
plexins A and B contains a CRIB-like (Cdc42/Rac-interactive binding) motif (Vikis et 
al., 2000). Recent evidence further shows that this region has an ubiquitin-like fold, 
which is also found in Ras-binding proteins space (Tong and Buck, 2005). 
Furthermore, this linker region is able to recruit other GTPases, such as RhoD and 
RND1 (Zanata et al., 2002). This link region is also referred to as GTPase-binding 
domain. Plexins can function as both ligand-binding receptor and signaling receptors 
for semaphorins. Most plexins interact with semaphorin through the sema domains of 
both proteins, except for class 3 semaphorins, which require neuropilins as essential 
semaphorin-binding coreceptors together with plexin-A (Takahashi et al., 1999). 
Neuropilins are transmembrane proteins with very short cytoplasmic domain that lack 
intrinsic enzymatic activity, and they alone fail to transduce the signals of 
semaphorins (Rohm et al., 2000a). They function as the ligand-binding partner in 
co-receptor complexes for both plexins and vascular endothelial growth factor 
receptors (VEGFRs) (Potiron and Roche, 2005). Different from neuropilins, plexins 
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have a large conserved cytoplasmic domain that can mediate semaphorin signaling 
together with the downstream effectors. The plexin signalings and their downstream 
effectors will be discussed in detail below. Sema3A shows repulsive effects on axons 
of dorsal root ganglion (DRG), sympathetic ganglion, spinal motorneurons, cerebral 
cortical neurons and hippocampal neurons (Nakamura et al., 2000) by binding to 
neuropilin-1/plexin-A complex and inducing repulsive responses. On the other hand, 
Sema3F binding to neuropilin-2/plexin-A has been shown to induce pruning of 
hippocampal mossy fibers (Bagri et al., 2003). Sema4D induces growth cone collapse 
in hippocampal neurons and neurite retraction (Perrot et al., 2002). Plexin-B3 is a 
specific and functional receptor for Sema5A. Sema5A is expressed in 
oligodendrocytes and their precursors, and it induces growth cone collapse of retinal 
ganglion cells, probably through plexin-B3 (Goldberg et al., 2004). 
Apart from the role in repulsive and attractive axon guidance (Tamagnone et al., 
1999), plexins have recently been shown to be involved in apoptosis of immature 
neural cells (Giraudon et al., 2004). Soluble CD100 (sCD100)/Sema4D released by 
activated T lymphocytes induced apoptotic death of multipotent neural progenitors 
after a progressive collapse of their process extensions. More recently, 
semaphorins/plexins have been further implicated in the development of the lung, 
heart (Giraudon et al., 2004; Kagoshima and Ito, 2001; Toyofuku et al., 2004), 
vascular system and epithelial structures (Fujii et al., 2002; Giraudon et al., 2004; 
Toyofuku et al., 2004), as well as in angiogenesis (Fujii et al., 2002; Giraudon et al., 
2004; Gitler et al., 2004; Serini et al., 2003; Torres-Vazquez et al., 2004) and invasive 
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growth of epithelial cells (Giraudon et al., 2004; Toyofuku et al., 2004). In addition, 
plexin-A1 are involved in alloantigen and peptide antigen stimulation of T cells and in 
the interaction of dendritic cells with T cells (Wong et al., 2003).  
In contrast to the heterophilic interaction with their ligands through the sema 
domain, plexins has been first found to establish homophilic interaction in trans 
through their extracellular domain in Xenopus (Ohta et al., 1995). Plexin-B3 has been 
found to mediate cell adhesion via a homophilic binding mechanism, under the 
presence of calcium ions and induce cell aggregation and neurite outgrowth as well. 
The similar homophilic interaction in trans has also been described in plexin-B2, 
resulting cell aggregation and neurite outgrowth (Hartwig et al., 2005).  
 
1.2.2 Plexin-B family and receptor complexes 
Among the four subfamilies, plexin-A family is the best characterized so far in 
terms of expression and functions. All four members, plexin-A1, -A2, -A3 and -A4 
are widely but differentially expressed in the developing central and peripheral 
nervous system. Plexin-A family ligands Sema3 mediate both region-specific 
repulsive and attractive activities (Messersmith et al., 1995). Moreover, the disruption 
of the patterned pathways in several regions such as sensory and sympathetic nervous 
system and the cortex were observed in knockout mice lacking the genes encoding 
Sema3A or its receptor neuropilin-1 (Kitsukawa et al., 1997).  
As for plexin-B family members, their expression profiles have just been 
revealed recently (Worzfeld et al., 2004). The expression of plexin-B family members 
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were observed over time periods from early events involving migration of 
neuroepithelial cells to the maturation of neural circuitry in adulthood by distinct cell 
types in the nervous system. The expression patterns of plexin-B1 and plexin-B2 
show some overlaps: they are expressed in the neuroepithelium during early 
embryonic development, including the neuroepithelium of all brain ventricles, the 
spinal cord and the cerebellar primordium, and in selected neuronal populations. 
Differences in expression exist in regions such as the midbrain and cortex 
embryonically and in the cerebellum over postnatal periods. Although the ligand has 
not been identified for plexin-B2 thus far, it is plausible that plexin-B1 and plexin-B2 
may show a functional overlap in these regions. Distinct from other two members, 
plexin-B3 expression is initially restricted to cells in the white matter of the central 
nervous system. Expression starts perinatally, increases progressively over the first 
two postnatal weeks and then decreases sharply over adulthood. Interestingly, this 
spatiotemporal pattern of plexin-B3 expression coincides largely with the perinatal 
birth, migration and development of oligodendrocyte precursor during progressive 
axonal growth and myelination in the central nervous system. 
In contrast to the plexin-A family that needs neuropilins as co-receptors, 
B-family plexins directly bind to semaphorins and mediate their signaling. Plexin-B1 
binds to semaphorin 4D (Sema4D) (Tamagnone et al., 1999), and semaphorin 5A 
(Sema5A) has recently been identified to be high-affinity ligand of plexin-B3 
(Artigiani et al., 2004) while neuropilin is not required for these interactions. However, 
no ligand has been identified for plexin-B2 so far. The extracellular moiety of 
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plexin-B family members shows highest homology with the scatter factor family 
including c-Met and Ron among plexin families. Furthermore, the cytoplasmic 
domain of plexin-B family has a specific sequence responsible for binding PDZ 
domain-containing protein (PDZ-binding domain) at the C-terminus. Plexin-B1 
interacts directly with Rho-specific exchange factors, via their PDZ domain, activates 
RhoA/Rho-associated kinase pathway, implicated in the regulation of axon guidance 
and cell migration (Driessens et al., 2002; Hirotani et al., 2002). Rnd1 promotes the 
interaction between plexin-B1 and PDZ-RhoGEF and thereby dramatically potentiates 
the plexin-B1-mediated RhoA activation (Oinuma et al., 2003). The fact that this 
PDZ-binding domain is only present in plexin-B but not other plexin families may 
explain some specificity in the function of plexin-B family members.  
Receptors on the plasma membrane often oligomerize in the receptor complexes 
which allow for cross-talk between different signaling pathways. As indicated 
previously, plexin-As associate with neuropilins to mediate Sema3 signaling. Other 
transmembrane molecules, including cell-adhesion molecule L1 (Castellani et al., 
2002) and the receptor-type tyrosine kinase off-track kinase (Winberg et al., 2001), 
are functionally coupled to semaphorin receptors plexin-A. As for plexin-B family, 
c-Met and ErbB-2 have recently been suggested to specifically and stably associate 
with these semaphorin receptors and form the receptor complexes independent of 
ligand binding (Jo et al., 2000) .  
c-Met  The Scatter Factor Receptor family includes two members: the tyrosine 
kinase receptor c-Met for hepatocyte growth factor (HGF), encoded by the c-MET 
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proto-oncogene; and the receptor RON for the macrophage stimulating protein (MSP). 
They are disulfide-linked heterodimeric proteins with intrinsic kinase activity. 
Homology among semaphorins, plexins, scatter factors are found in their extracellular 
domains, all of which contain the sema domain and PSI domains. Different from 
semaphorins and plexins, scatter factors have a catalytic region and two tyrosines in 
their cytoplasmic portions that become tyrosine phosphorylated and recruit 
downstream effectors and adapter proteins upon receptor activation.  
Activation of the c-Met receptor after ligand stimulation induces invasive growth, 
which is implicated in a range of morphogenetic processes from branched 
tubulogenesis of epithelia to cancer invasion as well as metastasis (Trusolino and 
Comoglio, 2002). In CNS, the Scatter factors are involved in the chemoattraction of 
motor neuron axons as well as survival and outgrowth of sensory neurons. Moreover, 
the role of c-Met in neoplastic cell spreading has been clearly demonstrated (Di 
Renzo et al., 2000; Pennacchietti et al., 2003; Vande Woude et al., 1997). Expression 
of c-Met is also observed in primary oligodendrocyte precursor cultures. Activation of 
c-Met signaling by its ligand HGF can enhance the proliferation and migration of 
primary oligodendrocyte precursors. c-Met also upregulates F-actin and β-tubulin, 
altering their distribution patterns, stimulating the outgrowth and migration processes 
of oligodendrocyte (Lalive et al., 2005; Yan and Rivkees, 2002).  
The extracellular domain of c-Met has been shown to interact with plexin-B and 
enhance invasive growth of cancer cells (Giordano et al., 2002). It is believed that the 
plexin-B1/c-Met interaction triggers invasive growth of epithelial cells, probably by 
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regulating c-Met signaling through its effectors GRB2 
(growth-factor-receptor-bound-2), GAB1 (GRB2-associated binder-1), SHC 
(Src-homology-2, SH2-containing), SHP2 (SH2-domain-containing 
protein-tyrosine-phosphatase-2), Src and/or PI3K (phosphatidylinositol 3-kinase). 
Plexin-B3 also associates in a receptor complex with c-Met, triggers the intracellular 
signaling of the c-Met receptor (Artigiani et al., 2004). It is possible that the plexin-B 
family can negatively regulate integrin function and leads to cellular collapse 
dependent specifically on the cytoplasmic domain of the plexins through Rho small 
GTPase, whereas they can also associate with c-Met to trigger the tyrosine kinase 
activity of c-Met, and activates the invasive growth program (Conrotto et al., 2004; 
Giordano et al., 2002). Furthermore, c-Met has been shown to interact with other 
proteins that drive receptor activation, transformation, and invasion. In neoplastic 
cells, c-Met is reported to interact with α6β4 integrin, a receptor for extracellular 
matrix components such as fibronectin and laminin, to promote HGF-dependent 
invasive growth by regulating actin cytoskeleton (Trusolino et al., 2001). Furthermore, 
CD44v6, which has been implicated in tumorigenesis and metastasis, was also 
reported to form a complex with c-Met and HGF and result in c-Met receptor 
activation (Orian-Rousseau et al., 2002).  
ErbB-2   The tyrosine kinase ErbB-2 has recently been suggested to stably associate 
with plexin-B family members (Swiercz et al., 2004). Activation of plexin-B1 by its 
ligand Sema4D stimulates intrinsic tyrosine kinase activity of ErbB-2, resulting in the 
phosphorylation of both plexin-B1 and ErbB-2 (Swiercz et al., 2004). ErbB-2 belongs 
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to subclass I of the receptor tyrosine kinase (RTK) superfamily, which consists of 
three other members: EGFR/ErbB-1, ErbB-3 and ErbB-4. Different from the scatter 
factor family, the extracellular domain of ErbB family does not have any homology 
with that of plexins or semaphorins. ErbB-2 is unique among the ErbB family 
members as it has no known ligand and can be activated only by oligomerization with 
ErbB-1, ErbB-3, and ErbB-4 or other tyrosine kinases (Olayioye et al., 2000; 
Yamauchi et al., 2000). Recent structural data show that the extracellular portion of 
ErbB-2 exists in an extended configuration that resembles the ligand-activated state 
and very likely interferes with ligand binding (Burgess et al., 2003). The ErbB-2 
receptors are expressed in various tissues of epithelial, mesenchymal and neuronal 
origin.  
The knock-out analysis of ErbB-2 has indicated that ErbB-2 plays essential roles 
in the development of both Schwann cell (Atanasoski et al., 2006; Lemke, 2006) and 
oligodendrocyte. ErbB-2 signaling governs a properly timed exit from the cell cycle, 
the process is not necessary for the early stage of oligodendrocyte precursor 
development, but is essential for pro-oligodendrocytes to differentiate into GalC+ 
oligodendrocyte during development into myelinating oligodendrocytes (Kim et al., 
2003; Park et al., 2001).  
Despite having no soluble ligand, ErbB-2 is important because it is the preferred 
heterodimerization partner of the other ligand-bound family members. The formation 
of receptor homo- and heterodimers of ErbB-2 receptor activates the intrinsic kinase 
domain, resulting in phosphorylation on specific tyrosine residues within the 
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cytoplasmic tail of ErbB-2. These phosphorylated residues serve as docking sites for a 
range of proteins, the recruitment of which lead to the activation of intracellular 
signaling pathways. For example, ErbB-3 has impaired kinase activity and only 
acquires signaling potential when it is dimerized with another ErbB receptor, such as 
ErbB-2. Over-expression of ErbB-2 in tumors leads to constitutive activation of 
ErbB-2. Many of these tumors contain phosphorylated ErbB-3, which couples ErbB-2 
to the phosphatidylinositol 3-kinase (PI3K)−AKT pathway (Holbro et al., 2003). 
 
1.3 Semaphorin-plexin signaling 
1.3.1 Small GTPase and cytoskeleton regulation 
Growth cone is a highly dynamic structure that is rich in actin and microtubule 
cytoskeleton, rendering it the ability of rapid change in shape and motility. 
Compelling evidence showed that growth cone responds to guidance cues through 
actin polymerization/depolymerization and cytoskeleton rearrangement (Dent et al., 
2003; Gallo and Letourneau, 2004; Gordon-Weeks, 2004; Kalil and Dent, 2005). 
Small GTPases of the Rho family are key regulators of cytoskeletal dynamics in 
non-neuronal cells (Narumiya, 1996) and now there is overwhelming evidence that 
they are involved in semaphorin-plexin signaling and regulate cytoskeletal dynamics 
in neuronal cells (Dickson, 2001).  
Rho GTPases act as molecular switches by cycling between GTP-bound (active) 
and GDP (inactive) states. In GTP-binding active form, Rho GTPases recruit kinases 
that regulate a variety of actin-binding proteins, so that their affinity of binding to 
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either actin monomers or F-actin is modified, resulting in cytoskeleton reorganization. 
Among numerous Rho family members, Rho, Rac and Cdc42 are most intensively 
studied. It has been shown that RhoA activation enhances actomyosin contractility 
and leads to assembly of stress fibers, focal adhesion complexes; Rac promotes 
formation of lamellipodia and membrane ruffles; Cdc42 stimulates formation and 
extension of filopodia and microspikes (Hall, 1998; Luo et al., 1997). Three cellular 
proteins are the direct regulators of Rho GTPases. GTPase-activating proteins (GAPs) 
stimulate the intrinsic GTP hydrolysis activity of Rho GTPases, thereby inactivating 
the switch. Guanine nucleotide-exchange factors (GEFs) promote the exchange of 
GDP for GTP, thus activating small GTPases. Guanosine nucleotide dissociation 
inhibitors (GDIs) bind to Rho GTPases and keep them in inactive state by inhibiting 
their spontaneous activity of exchange from GDP to GTP. 
The downstream effectors of Rho GTPase family include ROK (Rho-kinase), 
PAK (p21-activated kinase), MLCK (myosin light chain kinase), PI4P5K 
(phosphatidylinositol-4-phosphate 5-kinase), N-WASP (Wiskott-Aldrich syndrome 
protein) and WAVE (WASP-like Verprolinhomologous protein). These proteins 
regulate actin dynamics at several points through diverse mechanisms (Bishop and 
Hall, 2000; Dickson, 2001; Zhao and Manser, 2005). As illustrated in Fig. 2 (Dickson, 
2001), there are several primary mechanisms for actin polymerization and 






Figure 2. Signal transduction pathways that link Rho GTPases to actin 
cytoskeleton. Regulation can occur at several points, including filament nucleation 
and branching, filament extension, retrograde flow and actin recycling. Red arrows 
indicate points at which extracellular guidance cues may exert their influence 
(Dickson, 2001).
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1.3.2 Small GTPase in plexin-B signaling 
Recent evidence indicates that semaphorin-plexin signals mainly through small 
GTPases, which then induce cytoskeletal rearrangement. 
Rac  Recent data suggest that Rac can directly interact with plexin-A1 and plexin-B1 
through the GTPase-binding motif located between two segmented GAP domains in 
the cytoplasmic tail whereas neither Rho nor Cdc42 binds directly to this region 
(Driessens et al., 2001; Rohm et al., 2000b; Vikis et al., 2000). GTP-bound Rac1 
normally activates the downstream effector p21-activated kinase (PAK) to initiate 
actin polymerization. After Sema4D binding, plexin-B1 suppresses Rac1 activity by 
recruiting activated Rac1 from its downstream effector PAK. Sequestration of active 
Rac1 by plexin-B1 from PAK inhibits Rac1-induced PAK activation, thereby 
inhibiting actin polymerization (Hu et al., 2001; Vikis et al., 2000; Vikis et al., 2002). 
Active Rac1 also functions to stimulate the localization of plexin-B1 to cell surface, 
enhancing Sema4D binding to the receptor plexin-B1 in COS-7 cells (Vikis et al., 
2002), suggesting possible functions of Rac1 upstream of plexins. Signaling Rac and 
plexin-B1 appears to be bidirectional; plexin-B1 regulates Rac function, and Rac 
modulates plexin-B1 activity. 
Rho  Recent studies suggested that plexin-B1 mediates Sema4D-induced collapse of 
axonal growth cone through RhoA activation in cultured hippocampal neurons and 
retinal ganglion cells (Swiercz et al., 2004). As mentioned above, plexin-B family has 
a PDZ-binding motif at C-terminus of intracellular domain that is unique in plexin-B 
family. Plexin-B1 indirectly activates RhoA through interacting with 
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leukaemia-associated Rho-GEF (LARG) and PDZ-RhoGEF (PRG) at the 
PDZ-domain-binding motif (Aurandt et al., 2002; Perrot et al., 2002; Swiercz et al., 
2002; Swiercz et al., 2004). They are members of the RGS-RhoGEF family that 
specifically activate RhoA. Sema4D binding to plexin-B1 stimulates the GEF 
activities of LARG and PRG, leading to activation of RhoA. Signaling mechanisms 
downstream of RhoA mediate Sema4D-induced axonal growth cone collapse and 
neurite retraction (Dwiercz et al., 2002). By contrast, RhoA does not seem to be 
required for plexin-A1-mediated COS-7 cell collapse, suggesting RhoA signaling may 
be unique for plexin-B family. 
Rnd1  The small GTPase Rnd1 has also been revealed to bind to both class A (Rohm 
et al., 2000b) and B plexins (Oinuma et al., 2006). Binding of Rnd1 to plexin-A1 is 
involved in Sema3A-induced cytoskeletal collaspse (Wong et al., 2003; Zanata et al., 
2002), which is blocked by RhoD as a possible mechanism for turning off the receptor. 
Rnd1 is a constitutively active GTPase that antagonizes the effect of RhoA by binding 
to and activating p190 RhoGAP (Wennerberg et al., 2003). Rnd1 has been shown to 
bind to the GAP-binding domain of these receptors stably. Interaction of Rnd1 with 
plexin-B1 promotes association of PDZ-RhoGEF with plexin-B1, potentiates RhoA 
activation, and finally induces COS-7 cell collapse (Oinuma et al., 2003). The fact 
that both p190 RhoGAP and PDZ-RhoGEF have been shown to be downstream 
effectors of plexin-B1 (Barberis et al., 2005; Oinuma et al., 2003) suggests seemly 
contradicting role of Rnd1/RhoA in plexin-B signaling. That these results partially 
conflict probably stems from the different cell types used in the assays. The exact role 
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of Rnd1 in plexin-B1-mediated RhoA activation is still unclear.  
Cdc42  Although Cdc42 is involved in regulation of cytoskeletal rearrangement, no 
direct studies suggested the functional interaction of Cdc42 with semaphorin/plexin 
signaling compared with Rac1 and RhoA. Cdc42 has been shown to interact with 
neither the intracellular domain of plexin nor the downstream effectors of plexin-B. In 
contrast, our team demonstrates that active form of Cdc42 can, similar to Rac, interact 
with the cytoplasmic domain of plexin-B3 only after disruption of an inhibitory 
interaction between the N-terminal and the C-terminal parts of plexin-B3 intracellular 
domain upon ligand binding. The exact role of Cdc42 in semaphorin/plexin signaling 
is still not clear.  
R-Ras GAP activity of Plexins  As mentioned above, the intracellular domain of 
plexins has two highly conserved regions that show sequence homology to a GAP 
domain, and are separated by a linker region, which in plexin-B1 harbors the 
GTPase-binding site. These conserved regions of plexin contain two arginine residues 
that are similar to those necessary for catalytic activity in GAPs (Rohm et al., 2000b). 
Mutating the two Arg motifs in plexin-B1 results in a loss of GAP activity, and 
abolishes the Sema4D-induced collapse of COS-7 cells (Negishi et al., 2005). It has 
recently been established that both plexin-A1 and plexin-B1 possess GAP activity for 
the Ras family GTPase R-Ras (Oinuma et al., 2004). Plexin-B1 binds to GTP-bound 
R-Ras, and this interaction requires Rnd1 binding to the GTPase-binding region of 
plexin-B1 first, which is proposed to disrupt an inhibitory interaction between the 
N-terminal and C-terminal parts of the segmented GAP domain to allow R-Ras 
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binding and facilitate catalytic activity (Oinuma et al., 2006). Following that, 
plexin-B1 stimulates R-Ras’s GTPase activity. Therefore, stimulating the GAP 
activity of plexin-B1 requires both ligand binding to the extracellular domain and 
Rnd1 binding to its cytoplasmic domain. Compared with other Ras-family members, 
R-Ras signaling properties are distinctive. R-Ras primarily functions to regulate 
integrin activity, instead of having effect on ERK/MAPK. Constitutively active R-Ras 
increases integrin-based cell adhesion to the extracellular matrix (ECM), whereas 
dominant negative R-Ras abolishes this effect (Keely et al., 1999). Furthermore, 
integrin inactivation has been shown to be an early event in Sema4D-induced COS-7 
cell collapse (Barberis et al., 2004; Oinuma et al., 2004; Oinuma et al., 2006) and is 
important for cell motility that is regulated by semaphorins (Oinuma et al., 2004; 
Serini et al., 2003). More recently, Sema4D/plexin-B1 signaling has been shown to 
inactivate R-Ras through R-Ras GAP activity, and control cell migration by 
modulating the activity of β1 integrin (Ito et al., 2006). It has therefore been proposed 
that the GAP activity of plexins decreases active R-Ras, leading to the detachment of 
cells from the ECM.  
 
 
1.4 Role of semaphorins and plexins in development of oligodendrocyte 
Oligodendrocytes are myelinating cells in the central nervous system. In early 
myelinogenesis, oligodendrocytes elaborate highly branched processes that target and 
wrap axons to form the myelin sheath. The myelination is a compact lamellar 
wrapping that is essential for promoting rapid propagation of action potentials by 
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saltatory conduction. Recent studies also demonstrated that, besides myelin formation, 
oligodendrocytes also contribute to neuronal survival and development, as well as 
neurotransmission and synaptic activity (Antel, 2006; Chen et al., 2002; de and 
Bribian, 2005). 
1.4.1 Origin and development of oligodendrocyte 
The cellular origin of oligodendrocytes has been extensively studied; however, 
two apparently conflicting models have been established currently to explain the 
origin and lineage of oligodendrocytes. In the first model, local signals including 
sonic hedgehog (shh) firstly induce neuroepithelial cells in the ventral spinal to 
become a group of precursors that can give rise to both oligodendrocytes and motor 
neurons. After that, co-expression of Olig2 and Nkx2.2 results in the appearance of 
oligodendrocyte precursors cells (OPCs) (Zhou et al., 2001). After first arising in a 
restricted ventral part of the embryonic spinal cord, OPCs migrate laterally and 
dorsally. Another population of platelet-derived growth factor α (PDGFRα) positive 
OPCs appear to be generated from NKx2.2 expressing cells that do not express Olig2 
in dorsal spinal cord. Normally, the ventrally-derived precursors compete with and 
suppress their dorsal counterparts. There are also ventral and dorsal sources in the 
forebrain, but here the more dorsal precursors prevail and the ventral-most lineage is 
eliminated during postnatal life (Cai et al., 2005; Fogarty et al., 2005; Vallstedt et al., 
2005). In the other model, oligodendrocytes develop from glial restricted precursors 
(GRPs) that are immature cell restricted to generate only glial progeny. Although 
GRPs can be isolated from both the dorsal and ventral embryonic spinal cord, OPCs 
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arise specifically from the glial restricted precursors in ventral regions (Gregori et al., 
2002; Rao et al., 1998).  
After initial appearance in the ventral ventricular zone, OPCs migrate widely, 
mature through antigenically and morphologically distinct stages and finally form 
myelin internodes. At early stage, OPCs has been characterized by their bipolar 
morphology, mAb A2B5 immunoreactive and a mitogenic response to PDGF-AA and 
basic fibroblast growth factor (bFGF). These cells are actively proliferating and 
possess migratory properties. They migrate from their sites of origin to developing 
white matter tracts, where OPCs settle down and then transform into 
pro-oligodendrocytes. Pro-oligodendrocytes are multipolar, proliferative, 
postmigratory cells that acquire the marker O4.  As onset of terminal differentiation, 
pro-oligodendrocytes become immature oligodendrocytes, characterized by 
appearance of the marker Galactosylceramide (GalC), and loss of expression of GD3 
and A2B5 antigens on cell surface. CNPase is the earliest known myelin-specific 
protein to be synthesized by developing immature oligodendrocyte. As 
oligodendrocytes mature, they develop with the regulated expression of terminal 
markers, such as myelin sheath basic protein (MBP), proteolipid protein (PLP) and 
oligodendrocyte glycoprotein (MOG), and the synthesis of myelin membrane. They 
become multipolar by the extension of several main processes that subsequently 
extend numerous branches. Mature oligodendrocytes undergo progressive remodeling 
of their process arbor from premyelinating to myelinating cells. These processes 
contact and wrap axons to form the compact myelin sheaths in CNS.  The multiple 
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steps in development and myelination of oligodendrocytes are regulated by distinct 
signaling systems.  
 
1.4.2 Semaphorin/plexin regulation of migration and development of 
oligodendrocyte 
The migration and differentiation of OPCs are required from origins in neural 
tube to final myelination stage, and and regulated by both cell-extrinsic factors and 
cell-intrinsic factors. Cell-intrinsic factors include olig-1, olig-2 and Sox10, which 
control cell fate specification, and p27Kip and p21CIP1 ('t Hart and van, 2004), which 
operate the termination of cell proliferation and initiation of differentiation at 
appropriate time during OPCs development. Cell-extrinsic factors consist of soluble 
and membrane-bound molecules. Some molecules regulate their proliferation and 
differentiation, while others, also known as guidance cues, govern their migration to 
the presumptive white matter. The guidance cues are categorized into two classes: 
short-range, such as Nogo and components of ECM; and long-range such as Netrin-1. 
In addition, growth factors, such as PDGFα, bFGFs and insulin-like factor, have 
essential role in proliferation, migration, differentiation and myelination of 
oligodendrocytes (de and Bribian, 2005). 
Besides the well established role in growth cone guidance, semaphorin family 
members and their receptor plexins have recently been shown to be involved in these 
regulatory mechanisms of oligodendrocytes. A broad spectrum of expression of 
semaphorins is detected in oligodendrocyte including classes 3 to 7 (Cohen et al., 
2003). The expression of plexin-A4 was first identified in OPCs and mediated 
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repulsion for process extension of OPCs which were coursed by Sema3A and Sema6A 
(Okada et al., 2007). Neuropilins was detectable in cultured OPCs, and the expression 
is reduced when they differentiate (Cohen et al., 2003; Kantor et al., 2004). Sema3A, 
presumably binding to plexin-A/neuropilin complex, was expressed at the optic 
chiasm and in the ventral spinal cord during OP migration and repels process 
outgrowth of OPCs. The expression of several collapsing response mediator proteins 
(CRMPs), which is known to be mediators of Sema3A signaling, were further 
characterized in oligodendrocyte (Ricard et al., 2000; Ricard et al., 2001). In contrast, 
the other family members of class 3 semaphorin, Sema3F demonstrated a trophic 
effect on oligodendrocyte from optic nerve explants, while Sema3C and Sema3E had 
no observable effect on OPCs (Cohen et al., 2003; Spassky et al., 2002). The 
expression of Sema4D was localized to oligodendrocytes and their myelin sheaths in 
mouse CNS. Further, this expression is positively regulated with the development of 
oligodendrocytes, and transiently upregulated following spinal cord injury for 1 
month (Giraudon et al., 2004; Moreau-Fauvarque et al., 2003; Ricard et al., 2000; 
Ricard et al., 2001). Sema4D/CD100 from activated T cells exhibited inhibitory effect 
on oligodendrocyte by inducing process collapse, and even death to neural precursor 
cells (Giraudon et al., 2004). The expression of multiple semaphorins, including 
Sema5A, was observed in optic nerve. Sema5A mRNA and protein was specifically 
expressed at the optic disc and along the optic nerve (Oster et al., 2003). Although the 
exact role of Sema5A on oligodendrocytes is still unclear, it is plausible to speculate 
on Sema5A’s potential function as an inhibitory sheath for optic nerve development 
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by restricting oligodendrocytes in optic nerve during oligodendrocyte development.  
As the interaction partners of plexin-B3, c-Met and ErbB-2 are also essential for 
the development of oligodendrocyte. c-Met has been shown to function in the early 
stage of oligodendrocyte development by influencing OPCs cytoskeleton organization 
and stimulating OPCs proliferation and migration (Yan and Rivkees, 2002). ErbB-2 
controls the exit of cell cycle and transducing a terminal differentiation signal and 
promotes the differentiation of prooligodendroblasts into GalC+ immature 
oligodendrocytes (Kim et al., 2003; Park et al., 2001). Although both c-Met and 
ErbB-2 have been shown to establish association with plexin-B3 in vitro, the 
interaction pattern of plexin-B3 with these receptors is still unclear and the functional 
relation of receptors in oligodendrocyte development in vivo still needs to be 
elucidated. 
 
1.5 Objectives of study 
As a novel axon guidance molecule, plexin-B3 has been identified to be the 
functional receptor for Sema5A. Until now, only limited information has been 
gathered on the physiological functions and signaling pathways of plexin-B3. 
Plexin-B3 expression in neonatal stage coincides with oligodendrocyte development, 
suggesting its implication in this process. In this project, endogenous expression of 
plexin-B3 in mammalian cell lines was screened and cell lines that express 
endogenous plexin-B3 expression were used as useful models to study the function of 
plexin-B3. Furthermore, to understand the function of plexin-B3 and its binding 
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partners c-Met and ErbB-2 in oligodendrocyte development, heterophilic interaction 
of plexin-B3 with c-Met and ErbB-2 and homophilic interaction of plexin-B3 
extracellular domain were characterized. To investigate the function of plexin-B3 in 
oligodendrocytes, the involvement of plexin-B3 in OLN-93 migration, process 
outgrowth and branching was studied. Following that, the downstream signalings of 
Sema5A/plexin-B3, such as small GTPases of Rho family Cdc42/Rac1, and CNPase, 




Chapter 2 Materials and Methods 
2.1 Plasmid constructs and molecular cloning  
2.1.1 Expression constructs 
The expression constructs for expressing deletion mutants of plexin-B3 
extracellular domain as GST or MBP fusion proteins were generated by subcloning 
the cDNA fragments of plexin-B3 extracellular domain into pGEX-KG vector or 
pMal-C2 vector (New England Biolabs) respectively. The mammalian expression 
construct pIRES2-EGFP/B3-iso was generated by subcloning full-length plexin-B3 
cDNA into pIRES2-EGFP vector (Clontech). The mammalian expression construct 
pIRES2-EGFP/B3-iso-∆CD-EGFP was generated by subcloning truncated form of 
plexin-B3 cDNA lacking the cytoplasmic domain into pIRES2-EGFP. The expression 
constructs pEX/sema5A ED-Fc and pEX/Sema5A FL-c-Myc were provided by Dr. 
David Sretavan (UCSF, California). pEX-Fc vector was modified from pEX/Sema5A 
FL-c-Myc  vector by replacing Sema5A coding sequence with multiple cloning site 
(MCS) of pCDNA3.1 vector. Details of cloning were described in respective sections 
in chapter 3. 
2.1.2 Polymerase Chain Reaction (PCR) 
Standard PCR reaction mix and thermal cycling program are listed in Table 1 and 
Table 2 respectively.  
2.1.3 Agarose gel electrophoresis 
Agarose gel was prepared by dissoluting powdered agarose in TAE buffer (40 
mM Tris-acetate, 20 mM sodium acetate, 1 mM EDTA, pH 8.0) using a microwave  
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Table 1. Standard PCR reaction mix 
Components Stock concentration 
Final 
concentration Volume/Reaction 
Template - - 50 ng 
Forward primer 5 pmol/µl 0.2 pmol/µl 1µl 
Reverse primer 5 pmol/µl 0.2 pmol/µl 1µl 
DNA polymerase 5 U/µl 0.2 U/µl 1µl 
Polymerase buffer 10× 1× 2.5µl 
dNTPs 5 mM 200 µM 1µl 
H2O - - Top up to 25 µl 
 
Table 2. Standard PCR thermal cycling program 
Step Process Temperature (°C) Time (minute) 
1 Melting 94 5 
2 Primer annealing * 1 
3 Extension 72 1 
4 Melting 94 1 
5 Primer annealing * 1 
6 Extension 72 1 
7 Melting 94 1 
8 Primer annealing * 1 
9 Final extension 72 10 
 repeat step 4-6 for 30 cycles 
* The primer annealing temperature is determined according to each primer pair. 
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oven.Gel solution was cooled down to about 60°C and poured into the gel caster 
containing the comb. Once the gel was set, it was mounted into the electrophoresis 
tank containing TAE buffer. DNA samples were mixed with 6×DNA loading dye 
(0.25% Bromophenol blue, 0.25% Xylene cyanol FF, 30% glycerol in H2O) before 
loading into the wells. After electrophoresis at 5 volts per centimeter of gel, the gel 
was stained in ethidium bromide solution (0.5 µg/ml) for 10 minutes, destained in 
H2O, and visualized on a ultra-violet (UV) light illuminator. Gel images were 
captured with a gel documentation system (Gel Doc, Bio-rad). 
2.1.4 Extraction and purification of DNA from agarose gel 
The DNA band of interest was quickly excised from agarose gel using minimal 
UV intensity to prevent DNA damage. The extraction of DNA was carried out using a 
chaotropic-based gel extraction kit (QIAquick, QIAGEN) according to 
manufacturer’s instructions. Briefly, the gel slice was incubated in the chaotropic 
buffer PE at 50°C until completely dissolved. The mixture was allowed to flow 
through the mini column by centrifugation at 13,200 rpm for 1 minute at room 
temperature. Buffer PN was applied to wash the column by centrifugation at 13,200 
rpm for 1 minute, and then spun for one more time. DNA was then eluted with 30 µl 
of ddH2O by centrifugation at 13,200 rpm for 1 minute. 
2.1.5 Ligation reaction 
After determining relative amount of insert and vector beforehand by gel 
electrophoresis, ligation reaction was set up following Table 3. The reactions were 
carried out at 16°C overnight for sticky-end ligation or room temperature overnight  
 31
 
Table 3. Ligation reaction system 
Dephosphorylation of vector (to prevent self-ligation) 
Restriction digested vector  x µl 
Shrimp alkaline phosphatase buffer 0.9 µl 
Shrimp alkaline phosphatase (Roche) 1 µl 
 Top up to 8.9 µl 
37°C, 10 minutes followed by 65°C, 15 minute for inactivation of SAP enzyme 
Dephosphorylated vector 8.9 µl 
DNA insert x µl 
10× T4 ligase buffer 2 µl 
T4 ligase (Roche) 1 µl 
H2O Add up to 20 µl final volume 
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for blunt-end ligation. 
2.1.6 Transformation 
Ligation product or plasmid was mixed with E.coli competent cells and 
incubated on ice for 30 minutes. The mixture was heat-shocked for 90 seconds at 
42°C in water-bath, followed by 2 minutes on ice. 1 ml of LB broth was added into 
the mixture and incubated for 1 hour at 37°C with shaking (160-180 rpm). The 
bacterial culture was plated onto agar plates with appropriate antibiotics and 
incubated overnight at 37°C.  
2.1.7 Plasmid preparation 
Mini- and midi-preparation of plasmids from bacteria were carried out using the 
GFX Micro Kit (Pharmacia) and MIDI-prep Kit (QIAGEN) respectively according to 
manufacturer’s instructions. The concentration of plasmid DNA was determined by 
measuring the absorbance at 260 nm (A260) with a spectrophotometer (Biospec-1601, 
Shimadzu). 
 
2.2 RNA extraction and semiquantitative RT-PCR 
2.2.1 Isolation of total RNA from cells 
Total RNA was isolated from cells using the RNeasy mini kit (QIAGEN) 
according to manufacturer’s instructions. Briefly, 1×104 to 2×106 cells were harvested 
and resuspended in 350 µl of Buffer RLT. Cells were homogenized by passing 
through QIAshredder (QIAGEN) at 13,200 rpm for 2 minutes to shear genomic DNA 
before loading onto the RNeasy mini columns. 350 µl of 70% ethanol was added to 
 33
homogenized lysate and mixed well. The whole solution was passed through the 
RNeasy mini-column by centrifugation at 13,200 rpm for 1 minute to allow RNA 
binding to membrane. The flowthrough was discarded. Buffers RW1 and RPE were 
applied successively to wash the column by centrifugation at 13,200 rpm for 1 minute. 
RNeasy column was then carefully transferred to a new 1.5 ml collection tube after 
the column was dried by centrifugation for 1 minute at 13,200 rpm. To elute, 30 µl of 
RNase-free water was added directly onto the RNeasy silica-gel membrane and 
allowed to flow through the membrane by centrifugation at 13,200 rpm for 1 minute. 
The elution step was repeated to enhance recovery. RNA obtained from this 
procedure was treated with DNase to eliminate genomic DNA if needed. The 
concentration of RNA was determined by spectrophrtometric measurement of 
absorbance at 260 nm (A260).  
2.2.2 Reverse transcription 
2 µg of total RNA and 1 µl of 0.5 µg/µl Oligo dT (Sigma Proligo, Singapore) 
were mixed in diethylpyrocarbonate (DEPC) treated water to a total volume of 10 µl. 
After 5-minute incubation at 70°C to remove RNA secondary structure, reaction was 
quickly chilled at 4°C. The mixture was prepared according to Table 4 and reverse 
transcription was carried out at 72°C for 10 minutes, followed by 42°C for 1 hour. 
First-strand cDNA obtained from this procedure was kept at -20°C. The PCR reaction 




Table 4. Reverse transcription reaction mix 
Components Stock concentration 
Final 
concentration Volume 
RNA/Oligo dT - - 10µl 
AMV RT buffer 5× 1× 4 µl 
AMV reverse transcriptase 
(Promega) 
10 U/µl 0. 5U/µl 1 µl 
dNTPs 5 mM 1 mM 4 µl 
RNase inhibitor 40 U/µl 2U/µl 1 µl 
Total volume   20µl 
 
Table 5. RT-PCR reaction mix 
Components Stock concentration 
Final 
concentration Volume/Reaction 
First-strand cDNA  - - 50 ng 
Forward primer 5 pmol/µl 0.2 pmol/µl 1 µl 
Reverse primer 5 pmol/µl 0.2 pmol/µl 1 µl 
Taq DNA 
polymerase (Qiagen) 5 U/µl 
0.025 U/µl 0.125 µl 
Taq buffer 10× 1× 2.5 µl 
dNTPs 5 mM 200 µM 1µl 
H2O Top up to 25 µl 
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2.3 In situ hybridization 
2.3.1 Preparation of hybridization probe 
The plasmid harboring cDNA fragment was linearized by appropriate restriction 
digestion to leave a 5’ overhang. The reaction system of transcriptional labeling of 
probe was set up according to Table 6. The reaction was carried out at 37°C for 2 
hours. Labeled probe was purified by passing through GFX column (Amersham 
Biosciences). 
The yield of labeled probe was estimated by the direct detection method. Serial 
dilutions of labeled RNA probe and RNA control were prepared as follows: 10 ng/μl, 
1 ng/μl, 10 pg/μl, 3 pg/μl, 1 pg/μl, 0.3 pg/μl, 0.1 pg/μl, 0.03 pg/μl, 0.01 pg/μl. 1μl 
aliquot of probe dilutions and the corresponding control dilutions was applied on a 
narrow strip of positively charged nylon membrane and fixed by crosslink with UV 
for 3 minutes. The membrane was then transferred to a staining jar containing 20 ml 
washing buffer (0.1 M Maleic acid, 0.15 M NaCl pH 7.5, 0.3% (v/v) Tween 20), and 
incubated for 2 minutes with shaking. After incubation for 30 minutes in 10 ml 
blocking solution, the membrane was probed with 10 ml anti-DIG (1:1000) / blocking 
solution for 30 minutes. After that, the membrane was washed twice, 15 minutes each, 
with 10 ml washing buffer, followed by equilibration in 10 ml detection buffer (0.1 M 
Tris-HCl, 0.1 M NaCl, pH 9.5) for 5 minutes. The membrane was then incubated with 
10 ml detection buffer containing NBT (100 mg NBT/ml in 70% dimethylformamide) 
and 35 μl BCIP (50 mg BCIP/ml in 100% dimethylformamide) in the dark overnight. 
The reaction was stopped by washing the membrane in ddH2O. The results were 
analyzed by the intensity of the spots. 
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Table 6. Reaction mix for in situ hybridization probe transcriptional labeling 
Reagents Stock conc. Final conc. Volume 
Linearized DNA - - 1 μg 
Labeling Mix 10× 1× 2 μl 
Transcription 
buffer 5× 1× 4 μl 
RNA polymerase 20 U/μl 2 U/μl 2 μl 
RNAase inhibitor 40 U/μl 1 U/μl 0.5 μl 
DEPC-ddH2O - - Top up to 20 μl 
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2.3.2 In-situ hybridization 
Cells were plated on PLL-coated coverslips. After incubation, cells were fixed with 
4% paraformaldehyde for 10 minutes. Coverslips were then washed with 
DEPC-treated PBS for 5 minutes twice, followed by DEPC-treated PBS containing 
100 mM glycine for 5 minutes twice. Coverslips were treated with DEPC-treated PBS 
containing 0.3% Triton X-100 for 15 minutes, and then washed with DEPC-treated 
PBS for 5 minutes twice. Coverslips were incubated with 0.1 M triethanolamine 
buffer, pH 8.0, containing 0.25% (v/v) acetic acid for 5 minutes twice. After 
incubation for 30 minutes with DIG easy Hyb (Roche) at room temperature, 
coverslips were incubated with 50-100 μl DIG-labeled probe (600 ng/ml to 800 ng/ml) 
and incubated at 42-47°C overnight in a humid chamber. 
Coverslips were washed with 2× SSC for 15 minutes twice at room temperature, 
followed by 1× SSC for 15 minutes twice at room temperature. Coverslips were then 
washed by 2× SSC containing 50% formamide at 52°C for 30 minutes twice, and then 
0.1× SSC for 30 minutes twice at room temperature. After incubation with buffer 1 
(100 mM Tris-HCl pH 7.5, 150 mM NaCl) for 10 minutes twice, coverslips were 
covered with blocking solution for 30 minutes, followed by blocking solution 
containing 1:800-1:1000 anti-DIG-AP for 2 hours in a humid chamber. Coverslips 
were then washed with buffer 1 for 10 minutes twice, and then buffer 2 (100 mM 
Tris-HCl pH 9.5, 150 mM NaCl) for 10 minutes twice. After that, coverslips were 
incubated with approximately 200 μl color solution (10 ml of buffer 2, NBT (100 mg 
NBT/ml in 70% dimethylformamide) and BCIP (50 mg BCIP/ml in 100% 
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dimethylformamide)), in a humid chamber for 18 hours in the dark. When color 
development is optimal, the color reaction was stopped by incubation with buffer 3 
(10 mM Tris-HCl pH 8.1, 1 mM EDTA). Coverslips were washed with distilled water, 
and then mounted using xylene-free mounting solution.      
 
2.4 Northern blot 
2.4.1 Non-radioactive Northern blot 
The specific cDNA probe was labeled with DIG-dUTP by PCR reaction 
according to manufacturer’s instructions (Roche). Briefly, PCR reaction mix was set 
up according to Table 7 and carried out according to the thermal cycling program 
listed in Table 8. After reaction, 5 µl of each reaction was subjected to electrophoresis 
in 7% agarose gel for about 1.5 hours. The bands on the gel were examined by 
ethidium bromide staining.  
1% denaturing agarose gel in 1× MOPS buffer (0.2 M 3-[N-morpholino] 
propanesulfonic acid (MOPS) pH7.0, 20 mM sodium acetate, 10 mM EDTA pH8.0) 
containing 2% formaldehyde was prepared and mounted into the electrophoresis tank 
containing 1× MOPS running buffer. Meantime, RNA samples were prepared by 
mixing with 1× MOPS, 6.5% formaldehyde and 50% formamide and incubated at 
55°C for 15 minutes. 3 µl of formaldehyde loading buffer was added to each sample 
before loading. The denaturing gel was pre-run for 5 min at 5 V/cm (70 V in this case) 
prior to sample loading. Electrophoresis was initially conducted at 100 V to allow 
rapid migration of RNA samples into gel. The voltage was then adjusted to 70 V  
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Table 7. Reaction mix for Northern blot probe labeling 
 Stock conc. Final conc. DIG-labeled probe 
Un-labeled 
probe 
Template DNA - 10 ng Variable Variable 
Upstream and 
downstream primers 5 pmol/µl 0.2 pmol/µl
1 µl each 
primers 
1 µl each 
primers 
Taq DNA 
polymerase(Qiagen) 5 U/µl 0.025 U/µl 0.125 µl 0.125 µl 
Taq buffer 10× 1× 2.5 µl 2.5 µl 
PCR DIG mix 10× 1× 2.5 µl - 
dNTP stock solution 10× 1× - 2.5 µl 
ddH2O - - Variable Variable 
Total reaction 
volume - - 25 µl 25 µl 
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Table 8. Thermal cycling program for labeling cDNA probe with DIG 
Step Process Temperature (°C) Time (minute) 
1 Melting 94 5 
2 Primer annealing * 1 
3 Extension 72 1 
4 Melting 94 1 
5 Primer annealing * 1 
6 Extension 72 1 
7 Melting 94 1 
8 Primer annealing * 1 
9 Final extension 72 10 
 repeat step 4-6 for 30 cycles 
* The primer annealing temperature is determined according to each primer pair 
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thereafter. After electrophoresis, the denaturing gel was removed from electrophoresis 
tank and rinsed with 0.01% DEPC-treated water for several times to remove 
formaldehyde. For larger transcript (>5 Kb), RNA in gel was depurinated by rinsing 
in 0.05 M NaOH/1.5 M NaCl for no more than 10 minutes followed by 0.5 M Tris.Cl 
pH 7.4/1.5 M NaCl for 10 minutes. After washing, the gel was shaken gently in 10× 
SSC, diluted from 20× SSC (3M NaCl, 0.3 M Sodium Citrate) for 45 minutes. 
Nitrocellulose membrane was pre-wetted with deionised water, and then immersed in 
20× SSC for more than 5 minutes before transfer. The capillary transfer was set up 
using 20× SSC as transfer buffer. After blotting for 18 hours, membrane was rinsed 
briefly in 5× SSC for 5 minutes and RNA on membrane was fixed by UV crosslinking. 
The fixed membrane was wetted by 2× SSC and put into hybridization bottle. The 
membrane was incubated in prehybridization buffer. During prehybridization 
incubation, the labeled probe in 50 µl DEPC-H2O was denatured at 95°C for 5 
minutes and added into the hybridization buffer. The prehybridization buffer was then 
discarded and replaced with hybridization solution containing labeled probe. 
Hybridization was carried out at 55°C for 16 hours. After hybridization was complete, 
the membrane was submerged in low stringency wash buffer (2× SSC/0.1% SDS) and 
incubated at room temperature for 5 minutes with shaking, followed by washing in 
preheated high stringency buffer (1× SSC/0.1% SDS) twice at 68°C, 15 minutes each. 
To detect hybridization signals, the filter was washed with washing buffer (0.1 M 
maleic acid, 0.15 M NaCl, 0.3% (v/v) Tween 20, pH7.5) at room temperature twice 
with shaking, followed by “blocking solution” for 30 minutes. The membrane was 
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then incubated in antibody solution (Digoxigenin-AP 1:10,000 diluted in “blocking 
solution”) for 30 minutes with shaking. Membrane was washed with washing buffer 
twice and equilibrated with detection buffer (0.1 M Tris-HCl, 0.1 M NaCl, pH9.5). 
The membrane was then incubated in the chemiluminescence substrate CDP-star 
working solution (Roche) at a concentration of 0.25 mM for 5 minutes at room 
temperature and exposed to X-ray film.  
2.4.2 Radioactive Northern blot 
Labeling of specific cDNA probe with 32P-dCTP was carried out following 
manufacturer’s instructions (Amersham MegaPrime labeling kit). Briefly, 50 µg of 
DNA template was mixed with 5 µl of random primer (nonamer) and denatured by 
heating up to 95°C for 5 minutes, followed by ice-chill. 10 µl of  “Labeling Mix”, 5 
µl of 32P dCTP solution and 2 µl of Klenow were added into the template/primer 
mixture. The labeling reaction was carried out at 37°C for 20 minutes. The labelled 
probe was purified by passing through G-50 spin column (Pharmacia Biotech) to 
remove unincorporated labeled nucleotides. Labeling efficiency of probe was 
determined by scintillation count. 
The procedures of radioactive Northern blot was similar to that of nonradioactive 
Northern blot except 32P-dCTP labeled probe replaced DIG-dUTP labeled probe. To 
detect 32P-labeled probe hybridized on membrane, the membrane was exposed 
directly to Phosphor Imager Screen after high stringency wash.  
 
2.5 Cell culture 
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The oligodendrocyte cell line OLN-93, fiberblast cell lines HEK293, COS-7 and 
NIH3T3, neuroblastoma cell lines Neuro-2a (N2a) and PC12, were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine 
serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin. PC12 was cultured in 
DMEM supplemented with 10% horse bovine serum (HCS). Cells were passaged with 
Trypsin-EDTA (0.05% Trypsin, 0.53 mM EDTA) every 2-3 days and grown in a 
humidified incubator at 37°C with 5% CO2.  
 
2.6 Antibodies 
Rabbit polyclonal anti-Plexin-B3 ED antiserum and anti-Plexin-B3 CD 
affinity-purified antibodies were produced in our laboratory. Mouse monoclonal 
anti-GST antibodies (B-14: sc-138) and rabbit polyclonal antibodies anti-cdc42 (P1: 
sc-87), anti-Neu (C-18: sc-284), anti-HA (Y-11: sc-805), anti-MBP (N-17:sc-809), 
anti-Met (SP260: sc-162) were purchased from Santa Cruz Biotechnology, Inc. Mouse 
monoclonal antibodies anti-CNPase, anti-GAPDH and goat anti-human IgG (Fc) 
affinity secondary antibody were purchased from Chemicon. Mouse monoclonal 
anti-Rac1 antibody was purchased from BD Bioscience. Goat anti-human IgG Fc 
antibody with peroxidase conjugate was purchased from Sigma. 
Secondary antibodies used included anti-rabbit IgG conjugated to horseradish 
peroxidase (HRP) and anti-mouse IgG conjugated to HRP. All the secondary 
antibodies were obtained from Pierce and used at a dilution of 1:5000. 
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2.7 Expression and purification of GST fusion protein 
2.7.1 GST fusion protein of deletion mutants of Plexin-B3 extracellular domain  
A single bacterial colony harboring the expression construct for expressing GST 
fusion protein of deletion mutants of plexin-B3 extracellular domain was inoculated 
into 2 ml of LB broth containing 50 µg/ml of ampicillin and cultured for 14 hours. To 
induce expression of the protein, 1 ml of overnight culture was diluted in 2 ml of fresh 
LB broth supplemented with 50 µg/ml ampicillin and 0.5 mM 
Isopropyl-β-D-thiogalactopyranoside (IPTG). The culture was incubated at 30°C with 
shaking at 220 rpm. After 4-hour induction, the bacterial culture was centrifuged at 
13,200 rpm for 30 seconds at room temperature. The supernatant was then discarded 
and each bacterial pellet was resuspended in 300 µl of ice-cold 1× PBS. Cells were 
lysed on ice by sonication using a 2 mm probe. The lysate was subjected to 
centrifugation at 13,200 rpm for 10 minutes to obtain cleared crude cell lysate for 
subsequent purification.  
To prepare for GST fusion protein purification, Glutathione sepharose 4B (GSH 
4B) beads in the GST MicroSpin purification module (Amersham Biosciences) were 
resuspended by gentle vortexing and each column was placed into a 2 ml tube before 
spinning at 3,000 rpm for 1 minute at room temperature to remove the storage buffer. 
A total of 300 µl of the cleared crude cell lysate was transferred to the column and 
incubated for 30 minutes at room temperature with gentle mixing every 2 to 3 minutes 
for protein binding. The column was then spun at 3,000 rpm for 1 minute. GSH 4B 
beads in the column were washed with 500 µl of 1× PBS for 10 minutes, following by 
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centrifugation at 3,000 rpm for 1 minute. Washes were repeated for 2 additional 
rounds. Finally, any residual wash buffer was removed before resuspending resins in 
100 µl of PBS. The GST fusion protein bound to GSH 4B beads were then pooled in a 
single tube and stored at 4°C.  
2.7.2 GST-mPAK1 protein 
The procedure to express and purify GST-mPAK1 fusion protein that was used 
for PBD pull-down assay was similar to that of GST fusion protein of Plexin-B3 
deletion mutants. Briefly, protein expression was induced with 0.5 mM IPTG at 37°C 
for 2 hours. After centrifugation, the bacterial pellet was resuspended in 300 µl of the 
lysis buffer (20 mM Tris.Cl pH 7.4, 100 mM NaCl, 5 mM MgCl2, 0.05% (v/v) NP-40, 
1 mM phenylmethylsulphonylfluoride (PMSF), 1× Protease Inhibitor). Cells were 
lysed on ice by sonication using a 2 mm probe at an amplitude of 30 units, 15-second 
bursts for 3 times with 15-second intervals. A total of 300 µl of the cleared crude cell 
lysate was transferred to GST microspin column and incubated for 20 minutes at 
room temperature for protein binding. GSH 4B beads in the column were washed with 
500 µl of 1× PBS for 5 minutes, following by centrifugation at 3,000 rpm for 1 
minute. Washes were repeated for 2 additional rounds. Finally, any residual wash 
buffer was removed before resuspending resins in 100 µl of PBS. The GST fusion 
protein bound to GSH 4B beads were then pooled in a single tube and stored at 4°C.  
2.7.3 GST protein 
The procedure to express and purify GST protein that serves as control was 
similar to that of GST fusion protein purification. The induction was carried out at 
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37°C for 2 hours. The supernatant of bacteria culture was then discarded and each 
bacterial pellet was resuspended in 300 µl of 1× PBS. Cells were lysed on ice by 
sonication using a 2 mm probe at an amplitude of 30 units, 15-second bursts for 3 
times with 15-second intervals. A total of 300 µl of the cleared crude cell lysate was 
transferred to the column and incubated for 10 minutes at room temperature for 
protein binding. GSH 4B beads in the column were washed with 500 µl of 1×PBS for 
5 minutes, following by centrifugation at 3,000 rpm for 1 minute. Washes were 
repeated for 2 additional rounds. Finally, any residual wash buffer was removed 
before resuspending resins in 100 µl of PBS. 
 
2.8 Removal of GST moiety from GST-B3-ED-FL by thrombin-mediated 
cleavage 
After final wash in purification procedures of GST-B3-ED-FL-HA, 50 µl of 
Thrombin cleavage buffer (TCB) (500 mM Tris.Cl pH8, 1.5 M NaCl, 25 mM CaCl2, 
20 mM MgCl2, 1 mM DTT) and 1.3 µl thrombin (1 U/µl) (Amersham) were added to 
the column. The reactions were carried out at 4°C for 9 hours with agitation, followed 
by elution spin at 3,000 rpm for 1 minute to collect cleared proteins containing 
B3-ED-FL-HA and thrombin protease. To recover the residual B3-ED-FL-HA 
trapped in columns, 50 µl of TCB was then added to the column and gently mixed, 
after which columns were spun again so that the flowthrough could be pooled. 
Thrombin protease in eluate was removed by p-aminobenzamidine agarose beads 
(P-beads) (Sigma). 25 µl bed volume of P-beads was loaded to every 100 µl of 
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cleavage product and tubes were kept rotating at 4°C for 30 minutes to completely 
remove thrombin. The mixture was then spun at 3,000 rpm for 2 minutes and the 
supernatant (containing only B3-ED-FL-HA) was collected without disturbing 
P-beads at the bottom. The concentration of B3-ED-FL-HA protein in the supernatant 
was determined by BCA assay. The protein was stored in 50 µl aliquots at -80°C. 
 
2.9 Estimation of protein concentration using Bicinchoninic Acid (BCA) Protein 
Assay  
Concentration of protein was estimated by BCA assay. The corresponding buffer 
was used as blank and diluent in serial dilutions of bovine serum albumin (BSA) 
standard according to different protein samples. Nine dilutions of BSA were prepared: 
0 μg/ml, 25 μg/ml, 125 μg/ml, 250 μg/ml, 500 μg/ml, 750 μg/ml, 1.0 mg/ml,1.5 
mg/ml and 2.0 mg/ml. Samples were diluted with buffer at two ratios: 2:23, 4:21. 
Mixtures of 200 μl BCA reagent (Pierce) and 25 μl of diluted samples were incubated 
at 37°C for 30 minutes. Absorbance was measured immediately at 570 nm by 
Quant™ Microplate Spectrophotometer (Bio-Tek Instruments Inc). Results were 
analyzed using Prism3 (GraphPad Software). Standard curve was obtained using 
non-linear regression. Protein concentration of sample was taken as average of two 
values calculated from the dilutions.  
 
2.10 In vitro pull-down assay and GST pull-down assay 
2.10.1 Preparation of mouse brain protein lysate 
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Brains were immediately harvested from postnatal day 7 (P7) mouse, rinsed with 
ice-cold 1×PBS and frozen immediately in liquid nitrogen and stored at −80°C until 
use. To prepare brain lysate for in vitro pull-down assay, the frozen brain samples 
were homogenized with pre-cooled homogenizer in 1 ml of lysis buffer (20 mM 
Tris-HCl pH 7.4, 1 mM EDTA, 1% (v/v) Triton X-100, 1 mM dithiothreitol (DTT), 
1 mM phenylmethylsulphonylfluoride (PMSF), 1× protease inhibitor) on ice until no 
tissue clump was observed and then lysed for 1 hour at 4°C. The brain lysate was then 
centrifuged at 13,200 rpm for 15 min at 4°C three times to remove insoluble debris. 
The supernatant was collected and stored at -80°C until use. The concentration of 
protein in brain lysate was estimated by BCA assay. 
2.10.2 In vitro pull-down assay 
In vitro pull-down assay was performed to study interactions of purified 
recombinant proteins with endogenous proteins from brain lysate. Fixed amount of 
brain lysate of P7 mouse (~8 mg) was firstly diluted in 900 µl of pull-down buffer (20 
mM Tris-HCl pH7.4, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 1 mM PMSF) so that 
the final concentration of Triton X-100 was reduced from 1% to < 0.1%, which was 
then precleared with 20 µl GST protein pre-bound to GSH 4B beads for 1 hour at 4°C. 
The precleared brain lysate was mixed with 60 µl of GST fusion protein pre-bound to 
GSH 4B beads. For control, GST-bound sepharose with a concentration matching that 
of the highest concentration of GST fusion protein being tested was used. After 
overnight binding at 4°C with gentle agitation, GSH 4B beads were sedimented by 
centrifugation at 3,000 rpm for 1 minute at 4°C. GSH 4B beads, along with the 
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proteins bound to them, were washed in 500 µl of 1× PBS supplemented with 0.1% 
TritonX-100 for 5 minutes, followed by centrifugation for 1 minute at 3,000 rpm. Two 
additional washes were performed without the supplement of Triton X-100. 20 µl of 
1× SDS sample loading buffer was then added to each of the reaction tubes. 
Thereafter, centrifugation at 13,200 rpm for 1 minute was carried out, and the 
supernatant was saved for Western blot analysis. Anti-Met (1:1000) and anti-Neu 
(1:1000) antibodies were used to detect the bound proteins in in vitro pull-down assay. 
 
2.10.3 GST pull-down assay using recombinant proteins 
GST pull-down assay was performed to study interactions between purified 
recombinant proteins. Fixed amount of B3-ED-FL-HA protein (~35 µg) was mixed 
with GST fusion protein pre-bound to GSH 4B beads. The proteins were suspended in 
binding buffer (20 mM Tris-HCl pH7.4, 150 mM NaCl, 1 mM EDTA, 0.1% 
TritonX-100, and 1 mM DTT) to make up a total volume of 300 µl in each reaction 
tube. For control, GST protein alone replaced GST fusion protein, with the 
concentration matching to the highest concentration of GST fusion protein being 
tested. After 2-hours incubation at 4°C with gentle agitation, GSH 4B beads were 
sedimented by centrifugation at 3,000 rpm for 1 minute at 4°C. GSH 4B beads, along 
with the proteins bound to them, were then washed with 500 µl of 1× PBS buffer 
supplemented with 0.1% TritonX-100, followed by centrifugation for 1 minute at 
3,000 rpm at 4 °C. Two additional washes were performed without the supplement of 
TritonX-100. Subsequent procedures were similar to that of the in-vitro pull-down 
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assay described above. Anti-HA antibody (1:1000) was used to detect bound 
B3-ED-FL-HA proteins.  
 
2.11 Expression and detection of plexin-B3 recombinant protein in mammalian 
cells  
One day before transfection, 1 to 3 x 105 cells were plated in M2 medium 
(DMEM supplemented with 10% FBS) in 6-well culture plate (Nunc) so that cells 
will be 80-90% confluent at the time of transfection the next day. The optimized 
plating density was 3×105 for HEK293, 2.5×105 for N2a, 2×105 for OLN-93 and 1×105 
for COS-7 per well in 6-well culture plate. 1 hour before transfection, M2 medium 
was replaced with DMEM. DNA-Lipofectamine 2000 complexes were prepared as 
follows: DNA (1.6 μg) and lipofectamine 2000 (Invitrogen) (4 μl) were separately 
diluted in 250 μl of OPTI-MEM I Medium (Gibco). After 5 minutes’ incubation, 
diluted lipofectamine 2000 was added into diluted DNA (total volume = 500 μl), 
mixed gently and incubated for 20 minutes at room temperature. DMEM was 
removed from culture. Complexes were added into each well and mixed gently. 
Normally, mixture was changed to M2 medium 3 hours after transfection. In the case 
of OLN-93 cells, the incubation time of DNA-lipofectamine 2000 mixture was 
increased to ~12 hours to increase transfection efficiency. Cells were incubated at 
37°C in a CO2 incubator for 18-48 hours posttransfection prior to testing for transgene 
expression.  
To harvest cells and extract recombinant proteins, cells were washed with 
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ice-cold 1× PBS and scraped off from culture dish using 1× PBS. Cells were spun 
down at 12,000 rpm for 5 minutes and the supernatant was removed. Cell pellet was 
resuspended in 100 µl RIPA lysis buffer (50 mM Tris-HCl pH7.4, 150 mM NaCl, 1 
mM EDTA, 1 mM Na3VO4, 1 mM NaF, 0.1% (v/v) TritonX-100 and 1×protease 
inhibitor). After 2-hour lysis at 4°C with gentle shaking, the samples were centrifuged 
at 12,000 rpm for 10 minutes at 4°C. Cell lysate (the supernatant) was collected and 
kept at -80°C for subsequent Western blot analysis. To release transmembrane protein 
from cell membrane, the concentration of TritonX-100 in RIPA buffer was increased 
from 0.1% to 1%. The concentration of proteins in cell lysate was determined by BCA 
assay. Anti-HA (1:200), anti-Plexin-B3 CD (1:200) antibodies and anti-Plexin-B3 
antiserum (1:200) were used to detect recombinant plexin-B3 proteins. Anti-CNPase 
(1:1000), anti-GAPDH (1:1000), anti-c-Met (1:1000) and anti-Neu (1:1000) 
antibodies were used to detect endogenous CNPase, GAPDH, c-Met and ErbB-2 in 
cell lysate respectively. 
 
2.12 Production of Sema5A-Fc conditioned medium 
HEK293 and COS-7 cells (3×105 and 1×105 per well in 6-well plate respectively) 
were transfected with the expression construct pEx/Sema5A-ED-Fc (1.6 µg per well) 
following standard Lipofectamine 2000 transfection protocol (see section 2.10 above). 
Cells transfected with the pEX-Fc construct alone were used as control. After 
recovered for 24 hours in DMEM supplemented with 10% FBS, transfected cells were 
cultured in serum-free medium for 3 days to collect Sema5A-Fc protein. The 
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conditioned medium was harvested and centrifuged at 12,000 rpm for 5 minutes to 
remove cell debris. To examine expression and secretion of semaphorin proteins, 20 
µl of supernatants were loaded into 8% SDS-PAGE gel and analyzed by Western blot 
with an HRP-conjugated antibody against human IgG-Fcγ domain (1:200). The 
relative concentration of Sema5A-Fc protein in conditioned medium was then 
determined by silver staining and compared against bovine serum albumin (BSA) 
standard or by western blot and compared with Fc protein standard.  
 
2.13 Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) 
and Western blot 
Protein samples were prepared for SDS–PAGE with 2×SDS loading buffer 
(0.25 M Tris.Cl pH 6.8, 0.2 M DTT, 8% SDS, 0.02% bromophenol blue and 20% 
glycerol). The samples were routinely resolved by 6-10％SDS–PAGE gel at 150 V for 
45 minutes. Following electrophoresis, separated proteins were transferred to 
polyvinylidene fluoride (PVDF) or nitrocellulose membranes in the transfer buffer 
(25 mM Tris.Cl, 192 mM glycine, 20% methanol, pH 8.0) at a constant voltage of 
100 V for 1.5 hours at 4°C in the electrotransfer unit (Bio-Rad). Membranes were 
incubated in 2% MPBS (non-fat milk powder dissolved in 1×PBS) at room 
temperature for 1 hour and probed with primary antibody diluted in 3% BSA solution 
overnight at 4°C. The membrane was then washed with 1×PBS three times before 
being incubated with secondary antibody diluted in 2% MPBS for 1 hour at room 
temperature. After washing with 1×PBS for three times, the membrane was added 
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with the SuperSignal West Pico Chemiluminescent Substrate (Pierce) and signals 
were detected by exposure to X-ray film. For coomassie blue staining, the SDS-PAGE 
gel was stained with 0.02% coomassie Brilliant Blue G250 (Merck) and dried with the 
DryEase Mini-Gel Drying system (Invitrogen). 
2.14 Cell surface binding assay 
Cell surface binding assay was performed to study the binding of Sema5A-Fc to 
the surface of plexin-B3-expressing cells. Cells plated on coverslips in 6-well culture 
dish were incubated in serum-free medium supplemented with 1 mg/ml BSA at 37°C 
for 30 minutes to block non-specific binding, and then incubated in Sema5A-Fc or Fc 
conditioned medium supplemented with BSA (1 mg/ml) at room temperature for 60 
minutes. After binding, cells were washed twice with 1×PBS to remove non-specific 
binding and then fixed with 2% paraformaldehyde (PFA) for 10 minutes at room 
temperature. Endogenous peroxidase activity was blocked by incubating the cells with 
methanol:3% H2O2 (4:1 v/v) for 20 minutes at room temperature and non-specific 
binding was blocked with BSA/1×PBS (1 mg/ml) for 30 minutes. The cells were 
stained with HRP-conjugated anti-human IgG Fc antibody (Sigma 1:200) for 1 hour at 
room temperature, and then washed twice with 1×PBS. The bound Fc antibody was 
detected by revealing HRP activity using DAB peroxidase substrate (Sigma) 
following manufacturer’s instructions. Briefly, one DAB tablet and one Urea 
hydrogen peroxidase tablet were dissolved in 1 ml of deionized water. Cells were 
covered by DAB solution until the brown-black stain was visible. Reaction was 
stopped by gently washing cells with PBS. 
 54
 
2.15 Cell migration assay (transwell assay) 
To investigate the effect of Sema5A on the migration of OLN-93, cell migration 
assay for OLN-93 was performed using transwell with 5 µm pore size (Costar). 
Briefly, the uncoated or fibronectin-coated (10 µl/ml) transwell were pre-wetted with 
serum-free medium for at least 2 hours. OLN-93 cells were harvested from tissue 
culture flasks by 1 mM EDTA and resuspended in serum-free medium for the cell 
migration assay. Sema5A-Fc in conditioned medium was oligomerized by adding 
anti-human IgG Fc antibody into conditioned medium (7.5 µg/ml) at room 
temperature for 1 hour with gentle shaking. 600 µl of oligomerized Sema5A-Fc or Fc 
conditioned media was placed into the lower chamber of 24-well culture dish. 5×104 
cells in 100 µl was added into the upper chamber of transwell and incubated for 18 
hours in 37°C CO2 incubator. Cells remaining in the upper chamber were then 
removed by gentle and thorough cleaning the inner surface of membrane with a cotton 
bud. Cells that have migrated to the outer surface of membrane of transwell were 
stained with 0.2% crystal violet for 20 min at room temperature. At the end of staining 
procedure, excess stain was rinsed off with water.  The numbers of stained cells were 
counted and the pictures of transwell membrane were taken. 
 
2.16 Function assay of Sema5A on OLN-93 cells 
To investigate the effect of Sema5A on the morphology of OLN-93, OLN-93 
cells were plated in 6-well plate at a density of 2.5×104 per well and incubated in 2 ml 
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of DMEM supplemented with 10% FBS one day before Sema5A-Fc treatment. 
Culture medium was replaced by 1 ml of serum-free medium the next day 5 to 6 hours 
prior to Sema5A-Fc stimulation to allow acclimation of OLN-93 to serum-free culture 
condition. Meantime, Sema5A-Fc in conditioned medium was oligomerized by 
adding anti-human IgG Fc antibody into conditioned medium (7.5 µg/ml) at room 
temperature for 1 hour with gentle shaking. Serum-free medium was then aspired 
from OLN-93 culture and oligomerized Sema5A-Fc conditioned medium was added. 
Morphology of OLN-93 cells at various time points post-treatment was documented 
by photomicroscopy for subsequent analysis. The same set of treatment to OLN-93 
using conditioned medium containing Fc protein (at concentration equivalent to that 
of Sema5A-Fc) served as a control. The images were analyzed by counting the 
number of cells with multipolar or branching-process morphology, following by 
normalizing the result as a percentage of total number of cells in the whole culture.  
 
2.17 Rac1 and Cdc42 GTPase activation assay (PBD pull-down assay) 
To study the activation of Cdc42 and Rac1 upon Sema5A stimulation in OLN-93, 
PBD pull-down assay was performed. OLN-93 cells treated with Sema5A-Fc or Fc 
conditioned medium were harvested at the time indicated and lysed in lysis buffer (50 
mM Tris.Cl pH7.4, 150 mM NaCl, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, 1% (v/v) 
NP-40, 1×protease inhibitor, 10 mM MgCl2) for 30 minutes at 4°C with agitation. The 
samples were cleared by centrifugation at 12,000 rpm for 10 minutes at 4°C. Cell 
lysate (the supernatant) was collected and kept at -80°C. Protein concentration of cell 
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lysate was measured by BCA assay. 15 μl of GST protein pre-bound to GSH 4B 
beads was washed with 100 μl of core binding buffer (20 mM Tris.Cl pH7.4, 150 mM 
NaCl, 1 mM EDTA) and spun down at 3,000 rpm for 1 min at 4°C. To remove 
protein fractions that non-specifically bind to GSH sepharose, 150 μg of cell lysate 
was pre-cleared by adding to 300 μl of core binding buffer supplemented with 0.1% 
Triton X-100, 1 mM DTT, 1×protease inhibitor, 30 mM MgCl2, mixed well with 
washed glutathione sepharose 4B beads and incubated at 4°C for 45 minutes with 
gentle rocking, followed by centrifugation at 3,000 rpm for 1 min at 4°C. Precleared 
cell lysate was transferred to a new 1.5 ml tube. 60μl GST or GST-mPAKPBD 
protein pre-bound to GSH 4B beads were mixed with pre-cleared cell lysate and 
incubated at 4°C for 45 minutes with gentle shaking. After incubation, the beads were 
then washed twice with 500 μl of ice-cold 1×PBS for 5 minutes. The supernatant was 
aspired and 1×SDS sample loading buffer was added to the beads, and boiled at 95°C 
for 5 minutes. Thereafter, centrifugation at 13,200 rpm for 1 minute was carried out, 
and the supernatants were saved for Western blot. The bound Cdc42-GTP and 




Chapter 3 Results 
3.1 Characterization of expression of plexin-B3 at both RNA level and protein 
level 
Semaphorins and their receptors plexins play important roles in patterning the 
connectivity of the developing nervous system and recent data suggested that 
members of plexin-B family are involved in axonal guidance. The expression of 
plexin-B3 has been found in several fetal tissues including the brain, dorsal root 
ganglion (DRG), heart, lung and optic bulb by RT-PCR (Artigiani et al., 2004). At 
adult stage, plexin-B3 is widely expressed, especially abundantly in the brain. 
Furthermore, cell-specific isoforms of plexin-B3 with different 3’-ends of mRNA 
were identified in various adult human organs (Hartwig et al., 2005). As in brain, 
plexin-B3 mRNA is firstly detectable only perinatally and reaches maximum level at 
postnatal day 9 (Worzfeld et al., 2004). Whereas plexin-B1 and plexin-B2 are 
expressed in the neuroepithelium at the early stages and selected neural populations as 
development ensues, plexin-B3 expression is detected in both neurons widespread in 
the brain and population of white matter cells. This spatio-temporal pattern of 
plexin-B3 expression in whiter matter coincides largely with the perinatal birth of 
oligodendrocytes and their migration during progressive axonal growth and 
myelination in the central nervous system. Plexin-B3 expressing cells in the white 
matter tracts have already been identified to be oligodendrocytes but not astrocytes 
using combined in situ hybridization and immunocytochemistry by our team (Tang et 
al, unpublished data). Moreover, it has been shown that the expression of plexin-B3 
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and that of its ligand, Sema5A overlap in the brain, dorsal root ganglia and lung by 
semi-quantitative reverse transcription-PCR (RT-PCR) (Artigiani et al., 2004). This 
overlap of expression of plexin-B3 and Sema5A was further revealed by in situ 
hybridization results from our team. 
To elucidate the physiological function of plexin-B3 using cell-based approaches, 
we first screened for endogenous plexin-B3 expression in cell lines of various origins, 
including oligodendroglia OLN-93, neuroblastoma (N2a, PC12) and fibroblast 
(HEK293 and NIH3T3). 
3.1.1 Examination of endogenous expression of plexin-B3 mRNA 
To facilitate studies to understand the function of plexin-B3, its expression in 
several immortalized cell lines were examined by RT-PCR. OLN-93 was derived from 
primary rat brain glial cultures. Because its morphology and antigenic properties 
resemble primary bipolar O-2A-progenitor oligodendrocyte, OLN-93 represents a 
useful model system to investigate the specific mechanisms regulating the 
proliferation and differentiation of oligodendrocytes in vitro (Richter-Landsberg and 
Heinrich, 1996). N2a is a widely used mouse-specific neuroblastoma cell line and 
PC12 is a rat pheochromocytoma cell line displaying properties of differentiated 
sympathetic neurons after long-term exposure to nerve growth factor (NGF), 
including process outgrowth, electrical excitability, and functional synapse formation. 
Fibroblasts HEK293 and NIH3T3 transfected with plexin-B1 have previously been 
found to induce cellular collapse response upon stimulation by the ligand Sema4D 
(Swiercz et al., 2004). To adapt this assay system for functional characterization of 
 59
plexin-B3, we screened for endogenous plexin-B3 expression in these cell lines. 
Total RNA was extracted from these cells and reverse transcribed into cDNA. 
PCR was performed using cDNA of these cells as template. The primer pair 
PrPx11F1/PrPx15R1 was designed based on sequences (nt 2,599 to 3,433) that are 
conserved in mouse and rat plexin-B3, yet shown lowest homology with other 
members of the plexin families. Meanwhile, the human-specific primer pair 
hB3EDF1/hB3EDR1 was designed to amplify plexin-B3 (nt 2,365 to 2,863) from 
total RNA of HEK293 cells that was established from human embryonic kidney 
cultures. The PCR programs for amplifying mouse and human plexin-B3, and the 
internal control GAPDH were listed in Table 9. 
Among the cell lines tested, plexin-B3 was found to be expressed only in 
OLN-93 cells (Fig. 3A) as shown by the 835 bp band and the expression level was 
relatively low because the target band was still weak after amplifying for 30 cycles. 
The signal increased only after 33 amplification cycles (Fig. 3B). To exclude the 
possibility of non-specific amplification from other members of plexin-B family due 
to high homology, the RT-PCR product was sequenced. Sequencing results confirmed 
specific amplification of plexin-B3 by the primer pair PrPx11F1/ PrPx15R1. In 
contrast, plexin-B3 was not detectable in N2a, PC12, NIH3T3 and HEK293 cells (Fig. 
3A), suggesting these cells do not have endogenous expression of plexin-B3.  
In situ hybridization was further performed to confirm the presence of plexin-B3 




Figure 3. Examination of plexin-B3 expression in cell lines by RT-PCR. 
(A), RT-PCR analysis of expression of plexin-B3 in OLN-93, N2a, PC12, NIH3T3 
and HEK293 cells. RNAs obtained from cells were reverse transcribed and 
amplified with plexin-B3 specific primers. RT-PCR products derived after 32 cycles 
of amplification were analyzed by agarose gel electrophoresis. GAPDH served as 
internal control for all the extracted RNAs. (B), 5μl aliquots of plexin-B3 amplicon 
from OLN-93 cDNA were collected after amplification cycles 30, 33 and 36 for gel 
electrophoresis analysis. 
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Table 9. Primers for RT-PCR for examination of plexin-B3 expression 
PrPx11F1 5’-TGCAA CCCTG ACCCT TCTCT-3’ 
PrPx15R1 5’- CATGACTAAGTGGAGCCAGG -3’ 
hB3EDF1 5’-CAGTT TTATC CCTCC ATGTC-3’ 
hB3EDR1 5’-TGCCT GGTGG CTGGC TCTTA-3’ 
rGAPDHF1  5’-AGCAA TGCAT CCTGC ACCAC CAAC-3’ 
rGAPDHR1 5’-CCAGA GGGGC CATCC ACAGT CT-3’ 
hGAPDHF1 5’-TTTGC GTCGC CAGCC GAGC-3’ 
hGAPDHR1 5’-TTGGC AGCGC CAGTA GAGG-3’ 
 




cDNA template - - 50 ng 
Forward primer 5 pmol/µl 0.2 pmol/µl 1µl 
Reverse primer 5 pmol/µl 0.2 pmol/µl 1µl 
Taq DNA polymerase 5 U/µl 0.1 U/µl 0.5µl 
Taq buffer 10 × 1 × 2.5µl 
dNTPs 5mM 200 µM 1µl 




Table 11. RT-PCR thermal cycling program for examination of plexin-B3 mRNA 
expression 
Step Process Temperature (°C) Time (minute) 
1 Melting 94 5 
2 Primer annealing * 1 
3 Extension 72 1 
4 Melting 94 1 
5 Primer annealing * 1 
6 Extension 72 1 
7 Melting 94 1 
8 Primer annealing * 1 
9 Extension 72 10 
 repeat step 4-6 for 30 cycles 
* The primer annealing temperature is determined according to each primer pair. 
PrPx11F1/PrPx15R1, 61°C; hB3EDF1/hB3EDR1, 63°C; rGAPDHF 
/rGAPDHR, 61°C; hGAPDHF1/hGAPDHR1, 63°C. 
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28 of mouse plexin-B3 cDNA was cloned into pSP72 vector for subsequent 
generation of DIG-dUTP labeled hybridization probes. Hybridization result revealed 
that plexin-B3 transcript was detected by antisense probe (Fig. 4A) in OLN-93 cells 
but not by sense probe that served as a negative control (Fig. 4B).  
To quantify the expression level of plexin-B3 mRNA in OLN-93 cells, Northern 
blot was performed using specific probe against the extracellular (ED probe, 
nt.1107-2234) and cytoplasmic domain (CD probe, nt.3872-4916) of plexin-B3. The 
ED and CD probes were generated and labeled with DIG-dUTP by PCR using the 
primer pairs EDCF1/EDCR1 and CDAF1/CDBR1 respectively following 
manufacturer’s instructions. Labeling efficiency of PCR-generated probe was 
evaluated by gel electrophoresis (Fig. 5A and 5B). DIG-labeled probes apparently had 
significantly greater molecular weight than unlabeled probe, suggesting probes were 
labeled successfully. 
Northern blot was performed according to the protocol described in Materials 
and Methods. No target band (6.3 kb) was detected by either DIG dUTP-labeled ED 
or CD probe while GAPDH transcript was successfully detected by DIG-labeled 
GAPDH probe (data not shown). These results suggested that plexin-B3 transcript 
was possibly below the detectable level of non-radioactive Northern blot. To increase 
the sensitivity of detection, radioactive 32P-dCTP instead of DIG-dUTP was used to 
label ED and CD probe. 32P-dCTP labeling efficiency of probe was evaluated by 
measuring scintillation activity using scintillation counter. However, plexin-B3 







Figure 4. In situ hybridization to localize expression of endogenous plexin-B3 
mRNA in OLN-93 cells. OLN-93 was cultured for 2 days and analyzed by in situ 
hybridization using a plexin-B3 specific probe (A, antisense probe). Sense probe (B) 





Figure 5. Evaluation of DIG-labeled probes for Northern blot by gel 
electrophoresis. ED and CD probes were generated and labeled with DIG-dUTP by 
PCR labeling reaction. The labeling efficiencies were evaluated by gel 
electrophoresis. The labeled ED probe (A, lane 2) and CD probe (B, lane 2) have a 
significantly greater molecular weight and slightly stronger band intensity than 
unlabeled probes (A, lane 1; B lane1). 

















(data not shown). These results demonstrated that plexin-B3 transcript must be below 
the detectable level of Northern blot. This corresponded to semiquantitative RT-PCR 
results suggesting that endogenous expression of plexin-B3 in OLN-93 cells is 
relatively low.  
 
3.1.2 Analysis of recombinant and endogenous plexin-B3 protein in mammalian 
cell lines 
To express recombinant plexin-B3 protein, mammalian expression constructs 
pIRES2-EGFP/B3-iso and pIRES2-EGFP/B3 encoding the full length plexin-B3 (Fig. 
6A) were firstly constructed by subcloning the full length plexin-B3 cDNA with or 
without the alternatively-spliced exon at the juxtamembrane intracellular domain that 
encodes AGVGDQCRKETT (aa1289-1301) into pIRES2-EGFP vector respectively 
by EcoRI/BamHI restriction sites. pIRES2-EGFP vector contains the internal 
ribosome entry site (IRES) of the encephalomyocarditis virus (ECMV) between the 
MCS and the enhanced green fluorescent protein (EGFP) coding region (Fig. 6B). 
This permits both plexin-B3 (cloned into the MCS) and the EGFP gene to be 
translated bicistronically from a single mRNA. pIRES2-EGFP is designed for the 
efficient selection of transiently transfected mammalian cells expressing both EGFP 
and plexin-B3. 
To generate mammalian expression vector encoding the truncated form of 
plexin-B3 lacking cytoplasmic domain (pIRES2-EGFP/B3-iso-ΔCD-EGFP), 
pKO/B3-iso, which consists of full-length plexin-B3 with the isoform, was firstly 
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digested by HindIII/SmaI to remove the C-terminal fragment of plexin-B3. It was 
then subcloned with a HindIII/SmaI-EGFP fragment released from pCAP/EGFP#3 
plasmid. This EGFP fragment contains stop condon at 3’-terminus in frame with 
plexin-B3 cDNA. B3-iso-ΔCD-EGFP fragment was then released from 
pKO/B3-iso-ΔCD-EGFP by EcoRI/SalI restriction digestion and subcloned into 
pIRES2-EGFP via EcoRI/SalI sites to yield pIRES2-EGFP/B3-iso-ΔCD-EGFP. The 
cloning strategy was shown in Fig. 6C. 
To express recombinant plexin-B3 protein, HEK293 cells and N2a cells were 
transfected with pIRES2-EGFP/B3-iso according to the transfection protocol in 
Materials and Methods. The transfection efficiencies, indicated by fluorescence signal 
of EGFP, in HEK293 and N2a were around 40% and 60% respectively 48 hours 
post-transfection. The transfections were also performed on NIH3T3 and COS-7 cells 
but the efficiencies were very low. 
According to the size of full-length mouse plexin-B3 cDNA (5.9 kb), full-length 
plexin-B3 protein is predicted to be 1891 aa with a calculated molecular mass of 
207.19 kiloDaltons (kDa). Western blot analysis of cell lysate from HEK293 
transiently transfected with the expression construct pIRES2-EGFP/plexin-B3-iso 
encoding full-length mouse plexin-B3 with HA epitope at the N-terminus (Fig. 6A) 
revealed a specific band of about 270 kDa that was absent in empty vector-transfected 
cells (Fig. 7A). The specific band of 270 kDa was also detected in cell lysate of N2a 
cells transfected with plexin-B3 by both anti-HA antibody (Fig. 7B) and anti-B3 CD 




Figure 6. Cloning strategy for 
plexin-B3 mammalian expression 
vector. (A), Domain structure of 
full-length plexin-B3 and dominant 
negative form of plexin-B3. SP, 
signal peptide; ED, extracellular 
domain; TM, transmembrane domain; 
CD, cytoplasmic domain. (B), Vector 
map of pIRES2-EGFP. (C), Cloning 
strategy for plexin-B3 mammalian 
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truncated form of plexin-B3 lacking cytoplasmic domain (plexin-B3-ΔCD) was also 
detected by anti-HA antibody (Fig. 7B) but not by anti-B3 CD antibody (Fig. 7C) in 
N2a cell lysate transfected with pIRES2-EGFP/B3-iso-ΔCD-EGFP. Both full-length 
and truncated form of plexin-B3 proteins were detected in transfected N2a cells by B3 
ED antiserum (against the extracellular domain of pelxin-B3) (data not shown, 
because the background was too high). Data from our team revealed that the size of 
plexin-B3 protein in N2a cells transfected with pIRES2-EGFP/plexin-B3-iso was 
reduced to ~200 kDa after treatment of tunicamycin (data not shown).  Protein 
sequence analysis demonstrates that Plexin-B3 has ten potential N-glycosylation sites 
(Asn-X-Ser/Thr, X≠Pro) in its extracellular domain, the 270 kDa band possibly 
represents fully glycosylated, mature, full-length transmembrane plexin-B3 protein. 
Similar glycosylation were also observed in endogenous full-length plexin-B3 protein 
in mouse brain and confirmed by EndoH and tunicamycin treatment in which a 200 
kDa band corresponding to deglycosylated full-length plexin-B3 was detected 
(Hartwig et al., 2005). Besides, glycosylation of extracellular domain was also 
observed in other plexin family members plexin-B1 and plexin-B2 (Artigiani et al., 
2004).  
In addition, a short juxtamembrane fragment (AGVGDQCRKETT, aa1289-1301) 
in the cytoplasmic domain of mouse plexin-B3 was shown to be essential for 
successful translation of mouse plexin-B3 from mRNA to protein. When HEK293 and 
N2a cells were transfected with pIRES2-EGFP/B3 or pDNA3.1/B3, two plexin-B3 
expression constructs lacking this specific fragment, plexin-B3 mRNA was present in 
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the total RNA of transfected cells but the recombinant protein was undetectable in the 
cell lysate. Only in presence of this short fragment could the full-length plexin-B3 
protein be transiently expressed in transfected HEK293 and N2a cells. Although our 
data suggested that mRNA of this specific fragment is alternatively spliced from the 
full-length plexin-B3 mRNA in mouse brain, its presence is crucial to synthesis and 
maturation of recombinant plexin-B3 protein in HEK293 and N2a cells.  
As shown in the previous section, plexin-B3 mRNA was detected in total RNA 
of OLN-93 cells. At the protein level, endogenous plexin-B3 protein was also detected 
by anti-B3 CD antibody (1:200) in OLN-93 cells. The specific band was revealed to 
be around 300 kDa, which was much larger than the size of recombinant plexin-B3 
proteins. This difference possibly reflects different glycosylation patterns or 
alternative splicing.  
 
3.1.3 Summary of results 
In this section, expression of endogenous plexin-B3 was first examined in 
several immortalized cell lines. Plexin-B3 mRNA was only detected in total RNA of 
OLN-93 cells by RT-PCR and in situ hybridization but not Northern blot, suggesting 
that its expression level was relatively low. At the protein level, endogenous 
plexin-B3 protein was detected by anti-B3 CD antibody against its cytoplasmic 
domain in OLN-93 cell lysate. From the analysis of recombinant plexin-B3 protein 
expressed in N2a and HEK293 cells transfected with plexin-B3 expression constructs 
and endogenous plexin-B3 protein expressed in OLN-93 cells, plexin-B3 protein has 
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post-translation modification in its extracellular domain. Furthermore, the short 
juxtamembrane fragment in the cytoplasmic domain of plexin-B3 was essential for 
successful translation of plexin-B3 from mRNA to protein. 
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Figure 7. Western blot analysis of recombinant plexin-B3 protein in transiently 
transfected HEK293 cells and N2a cells and endogenous plexin-B3 in OLN-93. 
(A), Western blot analysis of recombinant plexin-B3 protein in transfected HEK293 
cells. HEK293 cells were transfected with the plasmid pIRES-EGFP/B3-iso and lysed 
48 hours post-transfection. The recombinant plexin-B3 protein in 25 µg of cell lysate 
was analyzed by Western blot using anti-HA antibody (1:200). HEK293 cells 
transfected with pIRES2-EGFP served as negative control. (B, C), Western blot 
analysis of recombinant plexin-B3 protein in transfected N2a cells. N2a cells were 
transfected with pIRES-EGFP/B3-iso or pIRES/B3-iso-ΔCD-EGFP and lysed 48 
hours post-transfection. The recombinant plexin-B3 or plexin-B3 ΔCD protein in 25 
µg of cell lysate were analyzed by Western blot using anti-HA antibody (B, 1:200) 
and B3-CD antibody (C, 1:200). (D), Endogenous expression of plexin-B3 in 25 µg 














B3 B3 ΔCD 
C 





IB: anti-HA  





3.2 Investigation of interaction of the extracellular moiety of plexin-B3 with 
c-Met and ErbB-2 
The receptor tyrosine kinas c-Met has been recently implicated in plexin-B 
signaling pathway. All plexin-B family members have been found recently to form 
receptor complex with c-Met in a ligand-independent manner. Stimulation of 
plexin-B1 and plexin-B3 by their respective ligands Sema4D and Sema5A 
respectively leads to activation of the tyrosine kinase activity of c-Met, resulting in 
c-Met dependent stimulation of invasive growth (Artigiani et al., 2004; Conrotto et al., 
2005; Conrotto et al., 2004; Giordano et al., 2002). Furthermore, all plexin-B family 
members stably associate with the receptor tyrosine kinase ErbB-2 (Swiercz et al., 
2004). Binding of Sema4D to plexin-B1 stimulates intrinsic tyrosine kinase of ErbB-2, 
resulting in the phosphorylation of both plexin-B1 and ErbB-2. To date, little is 
known about the functional interaction between plexin-B3 and ErbB2. 
The previous sections showed that plexin-B3 is expressed in the oligodendrocyte 
cell line OLN-93. Interestingly, the role of ErbB-2 and c-Met in oligodendrocyte 
development has been revealed recently. c-Met has been shown to regulate OPCs 
proliferation and migration by influencing OPCs cytoskeleton organization (Yan and 
Rivkees, 2002). ErbB-2 can promote the transition of prooligodendroblast to GalC+ 
immature oligodendrocytes by regulating the accurate time for exiting cell cycle and 
transducing a terminal differentiation signal (Kim et al., 2003; Park et al., 2001). 
Based on this evidence, we speculate that the interaction of plexin-B3 with c-Met and 
ErbB-2 may result in cross-talks of these signaling pathways and therefore regulates 
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the development and function of oligodendrocyte.  
To investigate the function of plexin-B3 in oligodendrocyte, the interaction of 
plexin-B3 extracellular domain with c-Met and ErbB-2 were firstly characterized. 
Deletion mutants of plexin-B3 extracellular domain were purified as GST fusion 
proteins and in vitro pull-down assays using brain lysate from postnatal day 7 mouse 
were performed to investigate binding ability of endogenous c-Met and ErbB-2 in 
brain lysate with these deletion mutants of plexin-B3 extracellular domain. 
 
3.2.1 Plexin-B3, c-Met and ErbB2 are expressed in the oligodendrocyte cell line 
OLN-93 
Before characterizing interaction patterns of plexin-B3 with c-Met and ErbB-2, 
endogenous expression of c-Met and ErbB-2 in OLN-93 cells was first examined by 
Western blot. OLN-93 cells were lysed with RIPA lysis buffer (RIPA, 1% Triton-X 
100, 1× Protease Inhibitor) and the concentration of cell lysate was determined by 
BCA assay. The endogenous expression of c-Met and ErbB-2 in 50 µg of whole cell 
lysate were examined by Western blot using anti-c-Met (1:1000) and anti-Neu (1:1000) 
antibodies respectively. The results showed that OLN-93 has endogenous expression 
of both c-Met (140 kDa, Fig. 8A) and ErbB-2 (180 kDa, Fig. 8B), therefore justifying 
further investigation of potential interactions between endogenous plexin-B3/c-Met 
and plexin-B3/ErbB-2 for regulating cellular functions in response to their ligands in 
the oligodendrocyte cell line OLN-93. 
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Figure 8. Examination of Met and 
ErbB-2 expression in OLN-93. The 
expression of c-Met (A) and ErbB2 
(B) in cell lysate of OLN-93 (50 µg) 
was detected by anti-c-Met (1:1000) 
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3.2.2 Generation of plexin-B3 extracellular domain fragments as GST-fusion 
proteins for in vitro pull-down assay 
To study the molecular interactions between plexin-B3 and its binding partners, 
the extracellular portion of plexin-B3 was divided into several subdomains, and each 
of them was expressed as a GST-fusion protein (Fig. 9): B3-ED-α (sema domain, 1st 
and 2nd MRS domains, a.a. 46 to 726), B3-ED-sema (sema domain, a.a. 46 to 402), 
B3-ED-MRS (1st and 2nd MRS domains, a.a. 351 to 726), B3-ED-β (3rd MRS domain 
and IPT domains, a.a. 667 to 1500).  
The deletion mutants were cloned by PCR using full-length plexin-B3 cDNA as 
template. PCR primers for generating these deletion mutants were designed to amplify 
the target fragments and add EcoRI and HindIII restriction sites at the 5’- and 
3’-terminus respectively. The PCR products of correct size were gel purified and then 
cloned into pCAP vector at EcoRⅤsite by blunt-end ligation. Fragments were then 
released from pCAP by EcoRI/HindIII restriction digestion and subcloned into the 
expression vector pGEX-KG via EcoRI/HindIII sites. The scheme to clone the sema 
domain of plexin-B3 into pGEX-KG vector to yield pGEX-KG/B3-ED-sema (Fig. 10) 
was used as an example to demonstrate the cloning strategy to generate deletion 
mutants in the form of GST-fusion proteins. Details of primer sequences and PCR 
conditions are listed in Table 12. 
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Figure 9. Schematic representation of the plexin-B3 receptor and deletion 
mutants. (A), Full-length plexin-B3. (B), Systematic functions of plexin-B3 
extracellular domain were expressed as GST fusion proteins. Domain identities were 
given in the key and were drawn roughly to scale. Abbreviations: sema, semaphorin; 
PSI, plexin, semaphorin, integrin domain; IPT, immunoglobulin-like regions in 




















Table 12. PCR primers for constructing pGEX-KG expression vector to express 
plexin-B3 deletion mutant as GST-fusion proteins 
Plexin-B3 ED 
Fragment Primer Primer sequence 
B3-ED-α EDAF 5’-AAT[GAATTC]ACCTGGTGCTGGCACCA-3’ 
 EDBR 5’-AAT[AAGCTT]ACTCCTCTAAGGAGGCAGG -3’ 
B3-ED-β EDCF 5’-AAT[GAATTC]CAGAGGCTTGCCCCCAG-3’ 
 EDDR 5’-AAT[AAGCTT]ACTGGACAGGGCCTAGAGC-3’ 
B3-ED-Sema EDAF 5’-AAT[GAATTC] AC CTG GTG CTG GCA CCA-3’ 
 EDAR 5’- AAT[AAGCTT]AGGCTATCGTGTGCCCATC-3’ 
B3-ED-MRS EDBF 5’- AAT[GAATTC]CTCCTGACTCCCCCGAG-3’ 
 EDBR 5’-AAT[AAGCTT]ACTCCTCTAAGGAGGCAGG-3’ 
 
Table 13. PCR reaction system for amplifying plexin-B3 deletion mutant 
fragments 
Components Stock concentration 
Final 
concentration Volume/Reaction 
Template - - 1 ng 
Forward primer 5 pmol/µl 0.2 pmol/µl 1 µl 
Reverse primer 5 pmol/µl 0.2 pmol/µl 1 µl 
Pfu DNA polymerase 5 U/µl 0.1 U/µl 0.5 µl 
pfu buffer 10× 1× 2.5 µl 
dNTPs 5 mM 200 µM 1 µl 




Table 14. PCR program for amplifying plexin-B3 deletion mutant fragments 
Step Process Temperature (°C) Time (minute) 
1 Melting 94 5 
2 Primer annealing * 1 
3 Extension 72 1 
4 Melting 94 1 
5 Primer annealing * 1 
6 Extension 72 1 
7 Melting 94 1 
8 Primer annealing * 1 
9 Extension 72 10 
 repeat step 4-6 for 30 cycles 
* The primer annealing temperature is determined according to each primer pair: 




Figure 10. Cloning strategy of GST-fusion protein expression construct of 
deletion mutants of plexin-B3 extracellular domain. The approach to clone sema 
domain of plexn-B3 into pGEX-KG expression vector was used as an example to 
demonstrate the cloning strategy of pGEX-KG expression constructs for generating 








SP CDTM sema MRS IPT 
Blunt-end ligation 
Release B3-ED-sema fragment by 
EcoRI/HindIII digestion and subclone into 
pGEX-KG vector via EcoRI/HindIII sites 
sema 
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The resulting expression constructs of these deletion mutants were transformed 
into BL21 E.coli competent cells. Protein expression from pGEX-KG vector is under 
the control of tac promoter, which is inducible by using the lactose analog isopropyl 
β-D-thiogalactoside (IPTG). Induced cultures were allowed to express GST-fusion 
proteins for several hours, after which cells were harvested and lysed by sonication. 
The bacterial lysate was cleared of cellular debris by centrifugation and applied 
directly to glutathione sepharose 4B (GSH 4B) beads in GSH columns. After the 
binding of fusion proteins to the matrix, beads were washed with PBS to remove 
non-specifically bound proteins. Bound GST-fusion proteins were kept immobilized 
for in vitro pull-down assay directly. While a detailed general protocol for purification 
of GST-fusion protein has been described in Materials and Methods, expression 
conditions of each of the plexin-B3 deletion mutant protein was optimized by 
modifying temperature and time for induction to prevent the formation of inclusion 
body and to increase solubility of fusion proteins. For instance, lower temperature 
(30ºC), longer induction time (3~4 hours) and longer binding time (30 minutes) have 
been found to dramatically improve the yield of GST-B3-ED-MRS fusion proteins 
(Fig. 11). The optimized conditions for expression and purification of these 
GST-fusion proteins are listed in the Table 15. 
The expression of recombinant proteins was examined by Western blot. 
Representative results of analysis were shown in Fig. 11. Western blot analysis of 
purified proteins by anti-GST antibody (1:1000) revealed that all of the recombinant 
proteins were successfully purified at expected sizes (GST-B3-ED-α, 102.41kDa; 
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Table 15. Optimized conditions for expression and purification of plexin-B3 
deletion mutants as GST-fusion protein. 
Induction 





30, 15-second bursts with 
15-second intervals ): the 




GST-B3-ED-α 30 4 5 30 
GST-B3-ED-sema 37 3 4 30 
GST-B3-ED-MRS 30 3 5 30 
GST-B3-ED-β 30 4 5 30 




Lane 1 2 3 4 5 6 7 8 
Temperature (ºC) 30 37 37 37 37 30 30 30 
Duration of IPTG 
induction (hour) 
3 1 2 3 3 1 2 3 
Binding time (minute) 30 10 10 10 30 10 10 10  
Figure 11. Optimization of expression and purification of GST-B3-ED-MRS. 
Optimization of expression and purification of GST-B3-ED-MRS shown here served 
as an example to demonstrate GST-fusion protein optimization procedures. 
Expression and purification of GST-B3-ED-MRS was optimized, and then evaluated 
by Western blot using anti-GST antibody. Lane 1: lower induction temperature 
(30ºC), longer induction time (3 hours) and longer binding time with GSH 4B beads 








Figure 12. Western blot analysis of GST-fusion proteins of deletion mutant of 
plexin-B3 extracellular domain. 0.5 µg of purified GST-fusion proteins were 









kDa 1      2       3      4       
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GST-B3-ED-sema, 65.75 kDa; GST-B3-ED-MRS, 68.9 kDa; GST-B3-ED-β, 88.4 
kDa) with satisfactory concentration (Fig. 12). The purified GST-fusion proteins were 
utilized in in vitro pull-down assays to investigate the interaction pattern of plexin-B3 
extracellular moiety.  
 
3.2.3 Identification of the c-Met-binding regions in the extracellular domain of 
plexin-B3 
All members of the plexin-B subfamily including plexin-B3, but not other plexin 
family members have been shown to associate specifically with c-Met tyrosine kinase 
in a stable receptor complex in the absence of their ligands, and binding of Sema4D to 
its receptor plexin-B1 can activate c-Met signaling and lead to tyrosine 
phosphorylation of both receptors (Conrotto et al., 2004). Recent evidence (Artigiani 
et al., 2004) further showed that, by activating its specific receptor plexin-B3, 
Sema5A can induce tyrosine phosphorylation of c-Met and trigger its intracellular 
signaling. Although the ligand-binding region and dimerization region of c-Met, 
which shows very high homology with plexin-B family members, is located in the 
sema domain (Kong-Beltran et al., 2004), much less is known about the binding 
regions in the extracellular domain of plexin-B3 that mediate its interaction with 
c-Met.  
To identify specific subdomains of plexin-B3 involved in the interaction with 
c-Met, an in vitro pull-down assay was developed. In this assay, the deletion mutants 
of plexin-B3 extracellular domain were generated as GST-fusion proteins and 
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immobilized on GSH-4B sepharose beads as described in the previous section. These 
GST-fusion proteins-sepharose beads complexes were incubated with 5 mg of total 
brain lysate of postnatal day 7 (P7) mouse previously pre-cleared with 20 µl of GST 
protein-bound sepharose, and the binding was assessed by immunoblotting for c-Met.  
As shown in Fig. 13, all the deletion mutants interacted with c-Met at different 
binding affinities while GST control showed no binding. Our results agreed with a 
recent report suggesting the association of plexin-B3 with c-Met in a receptor 
complex (Conrotto et al., 2004). Moreover, our results further suggest that 
plexin-B3/c-Met interaction is mediated by the extracellular moiety of plexin-B3 in a 
ligand-independent manner. Furthermore, GST-B3-ED-α, a truncated form of 
plexin-B3 harboring the sema and the first and second MRS domains but lacking the 
third MRS domain and IPT domains, interacted strongly with c-Met (Fig. 13A and B) 
while deletion of MRS domain from B3-ED-α (GST-B3-ED-sema) slightly 
compromised its interaction with c-Met (Fig. 13A and B). MRS sequence alone 
showed only weak binding with c-Met. This points to the important role of sema 
domain of plexin-B3 in interacting with c-Met. Interestingly, GST-B3-ED-β 
containing the third MRS and IPT domains also bound to c-Met and the binding 
affinity was obviously higher than that of GST-B3-ED-MRS but much lower than that 
of GST-B3-ED-α and GST-B3-ED-sema (Fig. 13A, B and C). These data reveal that 
sema domain is sufficient to mediate the plexin-B3/c-Met interaction while the 
C-terminus, possible IPT domains, of plexin-B3 are also involved in the interaction 





Figure 13. Plexin-B3 interacts with c-Met through its sema domain and IPT 
domain. Deletion mutants of plexin-B3 extracellular domain were expressed as GST- 
fusion proteins. These fusion proteins were subjected to in vitro pull-down assay using 
brain lysate of P7 mouse, and bound proteins were analyzed by Western blot. (A), 
c-Met interacts with GST-B3-ED-α, GST-B3-ED-sema and GST-B3-ED-β with 
different binding affinities. (B), Comparison of the binding affinity of GST-B3-ED-α, 
GST-B3-ED-sema with GST-B3-ED-MRS. (C), Comparison of the binding affinity of 
GST-B3-ED-MRS with GST-B3-ED-β. Upper panels showed bound c-Met and lower 










































association with IPT domains, is crucially implicated in the interaction with c-Met. 
 
3.2.4 Identification of the ErbB-2-binding regions in the extracellular portion of 
plexin-B3 
As indicated by (Swiercz et al., 2004), plexin-B family members stably associate 
with the receptor tyrosine kinase ErbB-2 through extracellular domain. Binding of 
Sema4D to plexin-B1 stimulates the intrinsic kinase activity of ErbB-2, resulting in 
phosphorylation of both plexin-B1 and ErbB-2. Interestingly, recent structural data 
showed that, different from c-Met family, ErbB-2 has no structure homology with 
plexin-B family (Stein and Staros, 2006; Tommasi et al., 2004). The extracellular 
domain of ErbB-2 consists of four domains and has a fixed conformation that 
resembles the ligand-activated state: the dimerization loop in domain II is exposed. 
This explains several of its unique properties: it has no known ligand and works as 
heterodimerization partner. Therefore, it is likely that ErbB-2 associates with 
plexin-B3 through different binding sites in the extracellular domain of plexin-B3 
compared with c-Met.  
To examine whether plexin-B3/ErbB-2 interaction shares the similar region with 
plexin-B3/c-Met interaction, in vitro pull-down assay was performed to investigate 
the specific region of plexin-B3 required for interacting with ErbB-2. The deletion 
mutants GST-B3-ED-α and GST-B3-ED-β were firstly used to examine the ability of 
the N-terminus and C-terminus of plexin-B3 extracellular domain to interact with 
ErbB-2 respectively. The results demonstrated that GST-B3-ED-α interacted 
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specifically and efficiently with ErbB-2 while GST-B3-ED-β showed only very weak 
interaction with ErbB-2 (Fig. 14A). To further map the potential ErbB-2 binding site 
in GST-B3-ED-α, this fragment was subdivided into two halves and each of them was 
expressed in the form of MBP-fusion protein: MBP-B3-ED-sema and MBP-B3- 
ED-MRS. MBP fusion protein expression system was adopted in this part of the study 
because the two target proteins could be expressed at a much higher level and at 
higher solubility as compared to GST-fusion protein expression system (Fig. 14B). In 
vitro pull-down assays were then performed to investigate the binding of ErbB-2 to 
these MBP-fusion proteins. The results showed MBP-B3-ED-sema interacted 
specifically with ErbB-2 but MBP did not (Fig. 14C). As for MBP-MRS, although 
many rounds of in vitro pull-down assays were performed, specific binding failed to 
be detected. The fact that the sema domain is present in both GST-B3-ED-α and 
MBP-B3-ED-sema but absent in GST-B3-ED-β or MBP-B3-ED-MRS indicates sema 
domain is sufficient for the association of plexin-B3 with ErbB-2 in the receptor 
complex ligand-independently. Moreover, IPT domain, which is present only in 
GST-B3-ED-β but absent in the other three deletion mutants, can also mediate 
specific though weak interaction between plexin-B3 and ErbB-2. This indicates that 
IPT domain is also involved in the association of plexin-B3/ErbB-2. 
Pervious results demonstrated that in developing primary hippocampal neurons, 
Sema4D-induced axonal growth cone collapse could be blocked by dominant-negative 
mutants of both ErbB-2 and c-Met, and both tyrosine kinases became phosphorylated 




Figure 14. ErbB-2 interacts with plexin-B3 through the sema and the IPT 
domains. Deletion mutants of plexin-B3 extracellular domain were expressed as 
GST-fusion proteins or MBP-fusion proteins. These fusion proteins were subjected to 
in vitro pull-down assay using brain lysate of P7 mouse, and bound proteins were 
analyzed by Western blot. (A), ErbB2 interacted strongly with GST-B3-ED-α but 
weakly with GST-B3-ED-β. (B), Expression and purification of MBP fusion protein 
of deletion mutants of plexin-B3 extracellular domain. 0.5 µg of purified fusion 
protein MBP-B3-ED-sema (lane 1) and MBP-B3-ED-MRS (lane 2) were subjected to 
SDS-PAGE analysis. Purified proteins were detected by anti-MBP antibody (1:5000). 
(C), MBP-B3-ED-sema interacted with ErbB-2 specifically. The band in the lane of 
MBP, which served as negative control, suggested a minor degree of non-specific 




































Our data further suggest that plexin-B3 can interact with both c-Met and ErbB-2 from 
brain lysate of P7 mouse independent of their ligands. Therefore, it appears likely that 
plexin-B3, c-Met and ErbB-2 associate in the same receptor complex in a 
ligand-independent manner. Further experiments are needed to determine whether 
c-Met and ErbB-2 can interact with plexin-B3 simultaneously and associate in a stable 
complex in in vivo setting. 
 
3.2.5 Summary of results 
This part of work attempted to characterize the interaction of plexin-B3 
extracellular domain with c-Met and ErbB-2, which were endogenously expressed in 
OLN-93 cells. The results showed that plexin-B3 extracellular domain interacted with 
both c-Met and ErbB-2 in the ligand-independent manner in vitro. These interactions 
were mediated mainly by the sema domain of plexin-B3 extracellular domain. 
Furthermore, the IPT domain of plexin-B3 extracellular domain was also involved in 
the interaction of plexin-B3 extracellular domain with c-Met and ErbB-2 while the 
MRS domain was not required for establishing these interactions. 
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3.3 Investigation of the direct homophilic interaction between plexin-B3 
extracellular domain and map the binding site of plexin-B3 
Homophilic interaction in trans has been first found between plexins in Xenopus, 
and this interaction was dependent on the extracellular domain of plexin (Ohta et al., 
1995). Beside plexins, the sema domain has been found to be one of the most 
important domains in the extracellular domain of semaphorins and Met/Ron. Sema 
domain is necessary and sufficient for dimerization of c-Met and soluble sema domain 
of c-Met can inhibit c-Met dimerization and functional receptor activation 
(Kong-Beltran et al., 2004). Previous results (Conrotto et al., 2004) and our study 
showed that association of plexin-B3/c-Met requires sema domain of both receptors. 
Based on this evidence, it is tempting to speculate that plexin-B3 may interact 
homophilically through its sema domain in the extracellular moiety in a similar 
fashion to c-Met. Revealed by coimmunoprecipitation (CO-IP) results recently 
(Hartwig et al., 2005), sema domain mediates homophilic association of plexin-B3. 
However, this study failed to address whether homophilic association of plexin-B3 is 
direct or through intermediate proteins in cell lysate that link two or more plexin-B3 
together. Furthermore, it was still unclear which subdomain(s) of plexin-B3 
extracellular moiety mediate(s) this homophilic interaction. GST pull-down assays 
using purified recombinant plexin-B3 protein were therefore performed to investigate 
the direct homophilic binding of plexin-B3 extracellular domain. 
 
3.3.1 Expression of GST-fusion protein of full-length plexin-B3 extracellular 
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domain and generation of HA-tagged full-length plexin-B3 extracellular motif 
recombinant protein 
3.3.1.1 pMal-C2/B3-ED-FL-HA expression construct  
Because full-length extracellular domain of plexin-B3 (3,592 bp) is beyond the 
amplification capability of Pfu polymerase, plexin-B3 extracellular domain was 
amplified in two fragments: N-terminus (2,315 bp) and C-terminus (1,692 bp), and 
then ligated together (Fig. 15A). Thrombin cleavage site and hemagglutin (HA) 
sequence were added at the N- and the C-terminus of full-length plexin-B3 
extracellular domain respectively. Thrombin cleavage site was utilized to release 
plexin-B3 extracellular domain from the fusion protein and HA sequence was used as 
an epitope tag to detect recombinant proteins after thrombin cleavage. 
N-terminus of plexin-B3 extracellular domain (nt.192-2,507) was amplified with 
Pfu polymerase using the primer pair EDAF1/ED1R, adding restriction sites EcoRI at 
the 5’-terminus and HindIII at the 3’-terminus respectively. The PCR product of 
correct size was then subcloned into pSP72 vector via EcoR  restriction site to Ⅴ
generate the plasmid pSP72/B3-ED-N. This plasmid was digested with EcoRI/HindIII 
to release B3-ED-N fragment for subsequent subcloning into EcoRI/HindIII-digested 
pGEX-KG vector to generate the plasmid pGEX-KG/B3-ED-N. Using this plasmid as 
template, B3-ED-N fragment plus thrombin cleavage site (B3-ED-N-TCS) was 
amplified by the primer pair ED2F/ED1R, adding restriction sites XbaI at the 
5’-terminus and HindIII at the 3’-terminus. The resulting PCR product B3-ED-N-TCS 
was then digested with SacI and subcloned into pSP72 vector via SacI to generate the 
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plasmid pSP72/ B3-ED-N-TCS.  
C-terminus of plexin-B3 extracellular domain (nt.2,056-3,748) was amplified by 
the primer pair ED3F/ED3R, adding restriction sites HindIII at the 5’-terminus and 
EcoRI at the 3’-terminus. The PCR product of correct size was subcloned into 
EcoRⅤ-digested pCAP vector to generate the plasmid pCAP/B3-ED-C. The fragment 
B3-ED-C was released from pCAP/B3-ED-C by HindIII/EcoRI restriction digestion 
and then subcloned into HindIII/EcoRI-digested pMH vector, resulting in the plasmid 
pMH/B3-ED-C. B3-ED-C-HA fragment was amplified by the primer pair 
ED4F/ED4R using pMH/B3-ED-C as template, adding HindIII restriction site at the 
3’-terminus. The fragment was digested with SacI and subcloned into pSP72 vector 
via SacI restriction site to yield pSP72/B3-ED-C-HA. 
B3-ED-C-HA fragment was released from the plasmid pSP72/B3-ED-C-HA by 
SacI/HindIII restriction digestion and subcloned into the plasmid 
pSP72/B3-ED-N-TCS via EcoRI/SacI sites to generate the plasmid 
pSP72/B3-ED-FL-HA.  
B3-ED-FL-HA fragment was released from the plasmid pSP72/B3-ED-FL-HA 
with XbaI/HindIII restriction digestion and subcloned into XbaI/HindIII-digested 
pMal-C2 expression vector to generate pMal-C2/B3-ED-FL-HA. 
3.3.1.2 pGEX-KG/B3-ED-FL-HA expression construct  
The fragment B3-ED-C-HA was released from the plasmid pSP72/B3-ED-C-HA 
by SacI/HindIII restriction digestion and then subcloned into SacI/HindIII-digested 
pGEX-KG/B3-ED-N plasmid to generate pGEX-KG/B3-ED-FL-HA (Fig. 15B).
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Table 16. Primers for constructing the expression construct for full-length 








Table 17. PCR reaction mix for amplifying full-length plexin-B3 extracellular 
domain fragment 
Components Stock concentration 
Final 
concentration Volume/Reaction 
Template - - 1 ng 
Forward primer 5 pmol/µl 0.2 pmol/µl 1µl 
Reverse primer 5 pmol/µl 0.2 pmol/µl 1µl 
Pfu DNA polymerase 5 U/µl 0.1 U/µl 0.5 µl 
Pfu buffer 10 × 1 × 2.5µl 
dNTPs 5mM 200 µM 1µl 




Table 18. PCR reaction system for amplifying full-length plexin-B3 
extracellular domain fragment 
Step Process Temperature (°C) Time (minute) 
1 Melting 94 5 
2 Primer annealing * 1 
3 Extension 72 1 
4 Melting 94 1 
5 Primer annealing * 1 
6 Extension 72 1 
7 Melting 94 1 
8 Primer annealing * 1 
9 Final extension 72 10 
 repeat step4-6 for 30 cycles 
* The primer annealing temperature is determined according to each primer pair, 
EDAF/ED1R, 58°C; ED2F/ED1R, 58°C ; ED3F/ED3R, 58°C; ED4F/ED4R, 58°C. 
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3.3.1.3 pGEX-KG/B3-ED-FL expression construct  
The plasmid pGEX-KG/B3-ED-β was first digested with SacI/HindIII to release 
the fragment B3-ED-β. This fragment was then subcloned into SacI/HindIII-digested 
pGEX-KG/B3-ED-N plasmid to generate the expression construct 
pGEX-KG/B3-ED-FL encoding full-length plexin-B3 extracellular domain without 
HA tag (Fig. 15C).  
 
Transformation of plasmids pMal-C2/B3-ED-FL-HA and 
pGEX-KG/B3-ED-FL-HA into BL21 E.coli competent cells, expression, and 
purification of the corresponding fusion proteins MBP-B3-ED-FL-HA and 
GST-B3-ED-FL-HA were performed as described in Materials and Methods. Some 
modifications were made to increase the yield of MBP-B3-ED-FL-HA and 
GST-B3-ED-FL-HA fusion proteins: 30°C as optimized induction temperature and 4 
hours as optimized induction time. 
Cleavage of GST-B3-ED-FL-HA and MBP-B3-ED-FL-HA was performed so that 
B3-ED-FL-HA was released from GST and MBP moiety respectively and added into 
solution phase of pull-down assays. The protease thrombin recognizes the consensus 
sequence Leu-Val-Pro-Arg-Gly-Ser, cleaving the peptide bond between Arg and Gly. 
This is utilized in pGEX-KG vector which encodes such a protease cleavage site 
allowing the removal of an upstream GST domain. The same thrombin cleavage site 
was added downstream of the MBP coding region and upstream of multiple cloning 
site (MCS) in modified pMAL-C2 vector. Thrombin cleavage of fusion proteins was  
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A mPlexin-B3 FL 






Blunt-end ligation into  
pSP72 vector 




Subcloned into  
pGEX-KG vector 
Blunt-end ligation into 
pSP72 vector 
Subcloned B3-ED-C-HA into  
pSP72/B3-ED-N-TCS vector 
Subcloned B3-ED-FL-HA 
into pmal-C2 vector 







Figure 15. Cloning strategy of pGEX-KG expression constructs encoding 
full-length plexin-B3 extracellular domain. (A), Cloning strategy of pMal-C2 
expression vector pmal-C2/B3-ED-FL-HA. (B), Cloning strategy of pGEX-KG 
expression vector pGEX-KG/B3-ED-FL-HA. (C), Cloning strategy of pGEX-KG 
expression vector pGEX-KG/B3-ED-FL. 
Subcloned B3-ED-βinto pGEX-KG/B3-ED-N  
via SacI /HindIIIsites 
SacI /HindIII digestion 
Subcloned B3-ED-C-HA into  
pGEX-KG/B3-ED-N via SacI/HindIII sites 
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performed as described in Materials and Methods. Expression, purification and 
cleavage efficiency of B3-ED-FL recombinant protein were examined by Western blot.  
As shown in Fig. 16, B3-ED-FL-HA protein obtained (A, lane 4 and B, lane 3) was of 
good quality in terms of both purity and concentration. Single band of expected size 
(197 kDa) was present in purified GST-B3-ED-FL-HA fusion protein (Fig. 16A, lane 
2). Cleavage efficiency was satisfactory, as exemplified by the minimal amount of 
uncleaved GST-ED-FL-HA fusion protein or MBP-ED-FL-HA fusion protein 
remained in the column, which was shown as upper band in Fig. 16A lane 1 and Fig. 
16B lane 1. There was some B3-ED-FL-HA protein trapped in purification columns 
after cleavage which was shown as lower bands in Fig. 16A lane 1 and Fig. 16B lane 1. 
All the GSH 4B beads in purification columns were loaded to gel and intensity given 
was stronger than what was given by 1/10 (10μl / ~100ul) of final product (Fig. 16A 
lane 4 and 16B lane 3); therefore, the loss was still acceptable. Some B3-ED-FL-HA 
protein was also trapped in P-bead samples (Fig. 16A lane 3 and 16B lane 2) because 
a small amount of sample solution was still left in order to not disturb the P-bead 
pellets and induce cross-contamination after centrifugation. All of the P-beads left 
were loaded to gel and it gave a band of B3-ED-FL-HA a bit stronger than final product 
indicating relatively small loss during removal of thrombin from B3-ED-FL-HA 
solution (Fig. 16A lane 3 and Fig. 16B lane 2).   
After each preparation, the concentration of B3-ED-FL-HA recombinant protein 














Figure 16. Thrombin cleavage and purification of full-length plexin-B3 
extracellular domain protein. (A), Full-length plexin-B3 extracellular domain 
carrying HA epitope at its N-terminus (B3-ED-FL-HA, lane 4) was firstly generated 
as GST-fusion protein (GST-B3-ED-FL-HA, lane 2) which was released by cleaving 
from the GST motif using thrombin. The purification of B3-ED-FL-HA was examined 
by anti-HA antibody (1:5000). Lane 1, GSH 4B beads after thrombin cleavage. Lane 
3, P-beads after thrombin removal. (B), B3-ED-FL-HA (lane 3) was firstly generated 
as MBP-fusion protein which was released by cleaving from the MBP motif using 
thrombin. The purification of B3-ED-FL-HA was examined by anti-HA antibody 
(1:5000). Lane 1, amylose resin after thrombin cleavage. Lane 2, P-beads after 
thrombin removal. 
 











3.3.2 Investigation of the direct homophilic interaction between plexin-B3 
extracellular domain and map the binding site of plexin-B3 
In order to determine whether there is direct homophilic binding between the 
extracellular moiety of plexin-B3, recombinant protein of the entire extracellular 
domain of plexin-B3 (B3-ED-FL-HA) was expressed and purified as described in the 
previous section. The protein B3-ED-FL-HA released from MBP fusion protein was 
used for GST pull-down assay (because B3-ED-FL-HA released from GST fusion 
proteins possibly induces non-specific binding with GSH-4B beads, this recombinant 
protein was not used in GST pull-down assay). In GST pull-down assay, 
B3-ED-FL-HA recombinant protein was incubated with GST-B3-ED-FL 
protein-coupled resin (without HA tag), followed by removing the supernatant and 
washing the resin with PBS to reduce non-specific binding. The specific binding was 
assessed by immunoblotting for bound B3-ED-FL-HA with anti-HA antibody 
(1:1000). The results (Fig. 17A) showed that B3-ED-FL-HA protein interacted 
specifically with GST-B3-ED-FL but not with GST protein that served as negative 
control. Because the purification of both GST-B3-ED-FL (as the bait protein) and 
B3-ED-FL-HA (as the prey protein), evaluated by immunoblotting (Fig. 16A and B) 
showed no non-specific protein presented, this homophilic interaction is direct 
between HA-tagged full-length plexin-B3 extracellular domain recombinant protein 
(B3-ED-FL-HA) and GST plexin-B3 extracellular domain fusion protein 
(GST-B3-ED-FL) in absence of any intermediate binding proteins. These results 
further suggest that the homophilic binding is stable and independent of ligand 
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binding because no ligand was included in the binding assay. 
To map the region of plexin-B3 extracellular moiety involved in this homophilic 
binding, GST pull-down assay was performed to study the binding of B3-ED-FL-HA 
protein to deletion mutants of plexin-B3 extracellular domain as described in 
Materials and Methods. These results showed that B3-ED-FL-HA protein bound 
specifically to GST-B3-ED-FL, GST-B3-ED-α, GST-B3-ED-sema, three deletion 
mutants containing sema domain. GST-B3-ED-MRS did not bind to B3-ED-FL-HA 
protein, suggesting deletion of sema domain and IPT domain abolishes binding. 
Interestingly, GST-B3-ED-β, the deletion mutant comprising the third MRS domain 
and IPT domains but lacking sema domain, could also interacted with B3-ED-FL-HA 
specifically but weakly. These data demonstrated that both sema domain and IPT 
domain but not MRS domain contribute to the direct homophilic interaction. 
Quantitative comparison of B3-ED-FL-HA binding revealed that GST-B3-ED-FL and 
GST-B3-ED-α had comparable binding affinities whereas GST-B3-ED-sema and 
GST-B3-ED-β had relatively weak binding, indicating the homophilic binding of 
plexin-B3 is mainly mediated by sema domain while IPT domain is also involved in 
this homophilic binding.  
This interaction pattern was different from those with c-Met and ErbB-2 in 
which sema domain of plexin-B3 extracellular domain mediates the interaction with 
c-Met and ErbB-2. The possible reason for this major difference is that B3-ED-sema 
recombinant protein we used (aa46-402) was only partial sequence of sema domain 





Figure 17. GST pull-down showing direct homophilic interaction of plexin-B3 
mediated by sema domain and IPT domain. Full-length plexin-B3 extracellular 
domain protein (GST-B3-ED-FL) and deletion mutants were immobilized on GSH 4B 
beads. These protein-sepharose bead complexes were incubated with purified 
B3-ED-FL-HA protein. Bound B3-ED-FL-HA protein was detected by anti-HA 
antibody (1:1000). (A), Direct homophilic interaction of plexin-B3 extracellular 
domain: GST-B3-ED-FL protein bound to B3-ED-FL-HA protein. GST protein served 
as negative control. (B), Homophilic interaction of plexin-B3 extracellular domain 
was mediated by the sema domain; B3-ED-FL-HA interacted with GST-B3-ED-FL 
and deletion mutants GST-B3-ED-α and GST-B3-ED-sema and GST-B3-ED-β with 



























bottom face of plexin-B3 sema domain, leaving the top face of the sema domain 
available for interaction with other ligands and receptors, such as c-Met and ErbB-2. 
Deletion of part of the bottom face of sema domain, to some extent, may interfere 
with plexin-B3 dimerization.  
 
3.3.3 Summary of results 
The objective of this section is to characterize homophilic interaction in trans of 
plexin-B3 extracellular domain. The results of GST pull-down assay using 
recombinant proteins suggested that plexin-B3 establishes direct homophilic 
interaction in its extracellular domain ligand-independently. The binding site of 
homophilic interaction was further mapped to the sema domain of plexin-B3 




3.4 Sema5A binds specifically to its receptor plexin-B3 in neuroblastoma and 
oligodendrocyte cell line  
Sema5A is the only known high-affinity ligand specific for plexin-B3 so far 
(Artigiani et al., 2004). By screening cells expressing different candidate receptors, 
Artigiani et al demonstrated that Sema5A only bound specifically to COS-7 cells 
transfected with plexin-B3 but not untransfected cells, and the binding of 
oligomerized Sema5A protein with plexin-B3 can induce c-Met-independent cellular 
collapse or c-Met-dependent invasive growth in plexin-B3-expressing fibroblast, 
epithelial and primary endothelial cells (Artigiani et al., 2004). In this part, the effect 
of Sema5A on the oligodendrocyte cell line OLN-93 that expresses endogenous 
plexin-B3 was investigated. To begin with, the extracellular domain of Sema5A was 
expressed as an Fc fusion protein (Sema5A-Fc) to test its interaction with cell surface 
plexin-B3. This reagent was then used to stimulate plexin-B3 in OLN-93 and probe 
for functional changes in section 3.5. 
 
3.4.1 Production of Sema5A-Fc conditioned medium  
To produce a secreted recombinant Sema5A protein (Fig. 18A), the extracellular 
portion of Sema5A, encompassing both its sema and thrombospondin domains was 
fused to the human IgG-Fcγ domain (Sema5A-Fc). Briefly, cDNA encoding 
full-length Sema5A extracellular domain was cloned into the mammalian expression 
vector pEX. Fc (Exelixis) in frame with the IgG-Fcγ domain. The resulting 
pEx/Sema5A-ED-Fc expression construct was transiently transfected into HEK293 
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and COS-7 cells and allowed them to grow for 3 days in the serum-free medium 
OPTI-MEM (Gibco). To examine whether Sema5A-Fc protein was successfully 
expressed and secreted, conditioned medium was harvested and 20 µl of aliquot was 
analyzed by Western blot with an HRP-conjugated anti-human IgG-Fcγ antibody 
(1:250) (Fig. 18B) and by silver staining (Fig. 18D). The target band of 170 kDa was 
detected at high intensity (Fig. 18B, lane 1, 2). The concentration of Sema5A-Fc 
protein in conditioned medium was then determined by Western blot and compared 
with Fc protein standards (Fig. 18C) or by silver staining and compared with bovine 
serum albumin (BSA) standards (Fig. 18E). The estimated concentration of 
Sema5A-Fc protein ranged from 10 to 20 nM and 5 to 10 nM in conditioned medium 
harvested from transfected HEK-293 and COS-7 cells respectively. The 
concentrations were sufficient for function studies. Fc protein used as control in the 
following experiments was prepared similarly as described for Sema5A-Fc protein. 
 
3.4.2 Confirmation of Sema5A-Fc binding to plexin-B3 on cell surface 
Prior to applying Sema5A-Fc conditioned medium to stimulate plexin-B3 on 
OLN-93, its ability to bind plexin-B3 was examined by incubating with N2a cells 
transfected with full-length plexin-B3 expression construct, followed by 
immunostaining with HRP-conjugated anti-human IgG Fc antibody. Conditioned 
medium containing Fc protein was used as control. Briefly, N2a cells were plated at 
2.5×105/well in 6-well culture dishes. Transfection was performed with 
Lipofectamine 2000 using 1.6 µg of pIRES2-EGFP/B3-iso and pIRES2-EGFP  
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Sema sema domain 
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TM transmembrane domain 
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Figure 18. Production of soluble form of Sema5A-Fc protein. (A), Domain structure 
of Sema5A and diagram of Sema5A extracellular domain-Fc fusion protein. (B), 
Western blot analysis of Sema5A-Fc recombinant protein in conditioned medium. 
Sema5A-Fc expressed in conditioned medium from HEK-293 (lane 1, 2) or COS-7 (lane 
4) collected 3 days post-transfection were tested for the presence of secreted Sema5A-Fc 
by Western blot with anti-human IgG Fc antibody (1:250). Fc protein expressed in 
conditioned medium from HEK293 (lane 3) and COS-7 (lane 5) served as control. (D), 
Sema5A-Fc protein expressed in conditioned medium from HEK293 (lane 1, 2) or 
COS-7 (lane 4) collected 3 days post-transfection were tested for the presence of 
secreted Sema5A-Fc by silver staining. Fc protein expressed in conditioned medium 
from HEK293 (lane 3) and COS-7 (lane 5) served as control. The concentration of 
Sema5A-Fc in conditioned medium was estimated by Western blot and compared with 
serially-diluted Fc protein standards (C) or by silver staining and compared with 
serially-diluted bovine serum albumin (BSA) standards (E). Fc standards in (C): lane 1. 
15 ng/µl, lane 2. 3 ng/µl, lane 3. 1.5 ng/µl, lane 4. 0.6 ng/µl, lane 5. 0.15 ng/µl, lane 6. 
0.06 ng/µl. BSA standards in (E): lane 1. 15 ng/µl, lane 2. 3 ng/µl, lane 3. 1.5 ng/µl, lane 
4. 0.6 ng/µl, lane 5. 0.15 ng/µl, lane 6. 0.06 ng/µl. 






































respectively. Transfected cells were then detached with 1 mM EDTA and replated at 
low density (1×104 cells/well) on coverslips coated with Poly-L-lysine (PLL, 10 ng/µl) 
in complete medium on 6-well culture dishes 24 hours posttransfection. After another 
24 hours, cell surface binding assay using conditioned medium containing 
Sema5A-Fc was performed according to the protocol described in Materials and 
Methods.  
Upon adding DAB as substrate for HRP, plexin-B3 expressing cells treated with 
Sema5A-Fc conditioned medium showed intense brown staining, which was absent in 
Fc control (Fig. 19A). Moreover, no staining was detected in N2a cells transfected 
with pIRES2-EGFP control vector after incubation in conditioned medium containing 
either Sema5A-Fc or Fc (Fig. 19A). Taken together, these results suggested that 
Sema5A-Fc fusion protein in conditioned medium interacted specifically with 
plexin-B3 on cell surface.  
OLN-93 is an oligodendrocyte cell line that expresses endogenous plexin-B3. As 
a first step to study the effect of Sema5A on this cell line, the ability of Sema5A-Fc in 
conditioned medium to bind to plexin-B3 on OLN-93 surface was examined. Briefly, 
OLN-93 cells were detached with 1 mM EDTA and replated at 1×104 cells /well on 
coverslips coated with PLL (10 ng/µl) in complete medium in 6-well culture dishes. 
After culturing for another 24 hours, cell surface binding assay using Sema5A-Fc 
conditioned medium was performed according to the protocol described in Materials 
and Methods. As shown in Fig. 19B, OLN-93 cells showed brown staining after 
incubating with Sema5A-Fc conditioned medium but no staining with Fc conditioned 
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medium, suggesting that Sema-5A, but not Fc protein, bound specifically to OLN-93 
cell surface. These data revealed that Sema5A-Fc could bind specifically to 
plexin-B3-expressing cells. These interactions were not due to non-specific binding of 
Sema5A-Fc protein to the surface of N2a cells or OLN-93 cells because Fc protein 
alone did not bind to either plexin-B3-expressing N2a cells or OLN-93 cells. 
Furthermore, no bound Sema5A-Fc was observed on the surface of N2a cells 
transfected with pIRES2-EGFP after incubation with Sema5A-Fc conditioned 
medium, suggesting that Sema5A/plexin-B3 interaction requires the extracellular 
domain of plexin-B3 and is not mediated by other unknown potential receptors of 
Sema5A. Compared with N2a cells transfected with plexin-B3, staining for 
surface-bound Sema5A-Fc on OLN-93 cells was relatively weak. This difference 
possibly resulted from the different expression levels of plexin-B3 in these cells: 
plexin-B3 was over-expressed and showed high expression in N2a cells while 
OLN-93 cells has relatively low endogenous expression as indicated in Fig. 3. 
 
3.4.3 Summary of results 
The interaction of Sema5A with plexin-B3 was confirmed in cell surface binding 
assay in this section. The results showed that Sema5A-Fc bound to the surface of N2a 
cells transfected with full-length plexin-B3 expression construct but not cells 
transfected with empty vector. Furthermore, Sema5A-Fc also bound to the surface of 
OLN-93 cell expressing endogenous plexin-B3. These results suggested that 




Figure 19. The secreted form of Sema5A specifically binds to plexin-B3 
(A), Bound Sema5A-Fc to surface of N2a cells transfected with plexin-B3 was 
detected by HRP-conjugated goat anti-human Fc antibody (1:200) that was further 
revealed by DAB substrate. Sema5A-Fc staining was shown in intense brown. 
Binding of Fc to N2a expressing plexin-B3 was negligible. Empty vector-transfected 
cells exhibited no significant staining with either sema5A-Fc or Fc. Scale bar =50 µm. 
(B), Bound Sema5A-Fc to the surface of OLN-93 cells was detected by 
HRP-conjugated goat anti-human Fc antibody (1:200) that was further revealed by 
DAB substrate. Sema5A-Fc staining was shown in intense brown. Binding of Fc to 
OLN-93 cells was negligible. Scale bars =50 µm. 
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3.5 Sema5A promotes outgrowth and branching of cellular processes but inhibits 
migration of OLN-93 
Semaphorins were firstly identified as repulsive axonal guidance molecules, but 
they have recently been shown to regulate cell migration and other cellular processes 
in a variety of cells. For example, Sema3A exerts an essential permissive role in the 
execution of vasculature remodeling by inhibiting adhesion of endothelial cells to the 
ECM (Serini et al., 2003). Activation of plexin-B1 negatively regulates cell adhesion 
and migration of NIH-3T3 cells (Barberis et al., 2004). Plexin-C1 inhibits cell 
adhesion and chemokine-induced migration of dendritic cells (Walzer et al., 2001). 
Semaphorin/plexin signaling apparently plays an important role in cell migration. As 
in the case of neuron/glial cells in CNS, semaphorins have also been found to control 
oligodendrocyte migration. Sema3A inhibits process outgrowth of oligodendrocyte 
progenitors (OP) while Sema3F mediates a trophic effect (Spassky et al., 2002).  
Semaphorin family members and their receptor plexins have recently been 
shown to regulate the development of oligodendrocytes. Sema3A, presumably 
binding to plexin-A/neuropilin complex, is expressed at the optic chiasm and in the 
ventral spinal cord during OP migration and repels process outgrowth of OP (Spassky 
et al., 2002). The expression of Sema4D, which is localized to oligodendrocytes and 
their myelin sheaths in mouse CNS, is upregulated during the development of 
oligodendrocytes, and transiently increased following spinal cord injury (Giraudon et 
al., 2004; Moreau-Fauvarque et al., 2003; Ricard et al., 2000; Ricard et al., 2001). 
Sema4D/CD100 from activated T cells exhibits inhibitory effect on oligodendrocyte 
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by inducing process collapse, and even death to neural precursor cells (Giraudon et al., 
2004). Semaphorin 5A is an integral membrane protein that is expressed in the 
developing vertebrate nervous system. Sema5A can function as an inhibitory cue that 
collapses both cultured fibroblast and retinal ganglion cell growth cones (Artigiani et 
al., 2004; Goldberg et al., 2004; Oster et al., 2003). In addition, sema5A also has 
permissive effects on both cultured epithelial and endothelial cells leading to enhance 
cell migration (Artigiani et al., 2004; Togari et al., 2000). However, the role of 
Sema5A and its receptor plexin-B3 in the migration and maturation of 
oligodendrocyte is still poorly understood. 
 
3.5.1 Sema5A inhibits the migration of OLN-93 cells 
To elucidate the involvement of Sema5A/plexin-B3 signaling in the migration of 
OPC, the effect of Sema5A on migration of an oligodendrocyte cell line OLN-93 was 
examined in a transwell cell migration assay. Briefly, OLN-93 cells were detached 
with 1.5 mM EDTA in PBS and resuspended in serum-free medium, seeded on the 
upper side of transwell chambers and incubated for 18 hours. Conditioned medium 
containing Sema5A-Fc was added into the wells. Cells migrated to the lower side of 
transwells were visualized by staining with crystal violet and the numbers were 
counted. As shown in Fig. 20, Sema5A demonstrated an inhibitory effect on the 
migration of OLN-93 cells: Sema5A-Fc conditioned medium reduced ~40% of the 
migration of OLN-93 cells compared with Fc control medium.  
Recent reports suggested that Sema4D/plexin-B1 signaling regulates cell 
 113
migration by modulating the activity of integrin through altering R-Ras activation 
(Oinuma et al., 2006). Moreover, integrin is involved directly or indirectly in 
migration of OPC: substrate of fibronectin promotes OPCs migration while blocking 
of β1-integrin inhibits the migration of neonatal OPCs from rodents in vitro 
(Tiwari-Woodruff et al., 2001). 
The involvement and requirement of integrin in Sema5A-induced inhibition of 
OLN-93 migration was investigated using the transwell assay. Transwell chambers on 
the lower side were coated with fibronectin (FN) at 10 µg/ml and OLN-93 migration 
was measured by counting migrated cells on the reverse side of transwell chambers. 
As shown in Fig. 20, comparison of cell migration upon Fc treatment between 
uncoated and FN-coated transwells showed no significant difference in cell migration, 
suggesting that OLN-93 migration is unlikely to depend on integrin.  About 35% of 
OLN-93 migration was inhibited by sema5A-Fc conditioned medium compared with 
Fc control medium on the fibronectin-coated transwell chambers. Comparing to 40% 
inhibition in uncoated migration assay, just a slight promotion of hapotactic migration 
was observed upon fibronectin coating. This enhancement was not significant enough, 
suggesting integrin might not be an essential mediator of the migration of OLN-93. 
 
3.5.2 Sema5A promotes cellular process outgrowth and branching of OLN-93 
cells 
To elucidate the role of Sema5A in the development and differentiation of  
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Figure 20. Sema5A-Fc inhibits the migration of OLN-93 cells in transwell 
assays. Effect of Sema5A-Fc on migration of OLN-93 cells was examined by 
transwell assays. Transwell chamber was either uncoated (A) or pre-coated with 10 
µg/ml fibronectin (B). Migrated cells were visualized by staining with crystal 
violet. Fc conditioned medium served as negative control. (C), Relative cell 
migration upon Sema5A-Fc was determined by the number of migrated cells 
normalized against the number of cells migrated upon Fc control on uncoated 
transwell chamber. Results are the mean±SEM of three independent experiments. 
Results are subjected to paired t test analysis, and the differences between 
Sema5A-Fc and Fc were deemed statistically significant, *P=0.0047 versus Fc 
control (uncoated), **P=0.0086 versus Fc control (FN-coated). 
* **
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oligodendrocyte, the effect of Sema5A-Fc conditioned medium on differentiation and 
development of OLN-93 cells was investigated. In their morphological features, 
OLN-93 cells resemble bipolar O-2A-progenitor cells. Only after grown at low 
density under serum reduced condition for 3 to 4 days can OLN-93 cells differentiate 
to a more arborized cell morphology (Richter-Landsberg and Heinrich, 1996). 
To assess the effect of Sema5A on OLN-93, cells were plated at 2.5×104 cells 
/well in 6-well culture dish to yield good cell morphology that facilitates analysis 
(otherwise cells plated at high density would form large clumps interconnected by 
long thin cellular processes). After grown in complete medium for 1 day, OLN-93 
cells were cultured in serum-free medium for 5-6 hours for acclimation prior to 
Sema5A-Fc stimulation. Sema5A-Fc in conditioned medium was oligomerized by 
anti-human IgG Fc antibody (7.5 µg/ml), and then added into OLN-93 cell cultures. 
The morphologic appearance of OLN-93 cells was documented by photomicroscopy 
(Fig. 21) 
When cultured in conditioned medium collected from untransfected HEK293 
cells in uncoated 6-well culture dish, OLN-93 cells showed bipolar morphology with 
long thin cellular processes (Fig. 21A), which was similar to its normal morphology 
when cultured under complete medium. Only after incubation for 3-4 days in this 
conditioned medium change of OLN-93 cell morphology was observed, indicated by 
outgrowth and branching of cellular process. Conditioned medium containing Fc 
control showed similar effect on OLN-93 cells to untransfected conditioned medium. 
No significant promoting effect on outgrowth and branching of OLN-93 cellular 
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processes was observed after 48 hours’ incubation: the percentages of multipolar 
OLN-93 cells were still at basal level upon Fc conditioned medium stimulation. 
Treatment of OLN-93 cells with conditioned medium containing oligomerized 
Sema5A-Fc increased significantly the percentage of cells with multipolar and 
branched-process morphology after 18 hours and the effect of Sema5A was still 
obvious at 28-48 hours (Fig. 21B). These results suggested Sema5A could promote 
outgrowth and branching of OLN-93 cellular process. According to previous results 
and our finding, plexin-B3, which is expressed endogenously in OLN-93 cells, is the 
only known high-affinity receptor for Sema5A. Furthermore, Sema5A also bound to 
the cell surface of OLN-93 cells. These facts collectively prompted us to speculate 
that the promoting effect of Sema5A on process outgrowth and branching of OLN-93 
is likely mediated through activation of plexin-B3 signaling. 
 
3.5.3 Sema5A-induced process outgrowth and branching in OLN-93 is mediated 
by plexin-B3 
To investigate the involvement of plexin-B3 signaling in relaying the Sema5A 
effect in promoting process outgrowth and branching in OLN-93, two approaches 
were adopted: 1) gain of function by over-expression of plexin-B3 in OLN-93; 2) loss 
of function by expressing a dominant negative form of plexin-B3 in OLN-93 cells. 
The gain-of-function approach was adopted to test if promoting effect of Sema5A on 
OLN-93 cellular process outgrowth and branching would be potentiated upon 
























































Figure 21. Sema5A promotes outgrowth and branching of cellular process of 
OLN-93. OLN-93 cells were incubated in oligomerized Sema5A-Fc or Fc conditioned 
medium for the time indicated. The morphologic appearance of OLN-93 cells was 
documented at the time points indicated. (A), Representative morphology of OLN-93 
cells treated with untransfected HEK293 conditioned medium (a), Sema5A-Fc (b) or 
Fc (c) conditioned medium for 18 hours. Photos on the right are high magnification 
view of cells in rectangles in the main photos. Arrows indicated the cells with 
multipolar or branched-process morphology. (B), Quantitation of OLN-93 cells with 
multipolar or branching morphology. The percentage of OLN-93 cells with multipolar 
or branching morphology was calculated. Results were subjected to a paired t test 
analysis, and the differences between Sema5A-Fc and Fc were deemed statistically 
significant (*P<0.05 vs. Fc control). Scale bars in main photo= 100 µm; in high 
magnification photo= 100 µm. 
* * *
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expression of a truncated form of plexin-B3 lacking the intracellular domain in 
OLN-93 cells, which was supposed to block its signaling pathways in a dominant 
negative manner. OLN-93 cells were transfected with pIRES2-EGFP/B3-iso or 
pIRES2-EGFP/B3-iso-∆CD-EGFP according to optimized transfection protocol for 
OLN-93 cells. On the second day post-transfection, transfected OLN-93 were 
detached from culture dish with 1.5 mM EDTA and replated at 2.5×104 cells/well in 
6-well plate. Cells were then cultured overnight to allow cells to attach. Subsequent 
procedures in challenging the cell with conditioned medium were similar to that 
described in the previous section. The results were analyzed by observing the 
morphology of EGFP positive cells under fluorescent microscope at the time indicated 
and calculating the percentage of cells with multipolar and branched processes 
morphology. 
The expression of full-length and truncated form of plexin-B3 protein was 
examined in cell lysate of transfected OLN-93 by Western blot (Fig. 22) using 
anti-HA antibody (1:250). The target bands of full-length plexin-B3 and truncated 
form of plexin-B3 were detected with the molecular weight of 270 kDa and 230 kDa 
as expected, respectively. As shown in Fig. 6B, pIRES2-EGFP vector contains an 
internal ribosome entry site (IRES) downstream of the coding region of plexin-B3 and 
upstream of the enhanced green fluorescent protein (EGFP) coding region. This 
permits both plexin-B3 and EGFP gene to be translated from a single mRNA in a 
bicistronic manner. The EGFP positive OLN-93 cells transfected with 
pIRES2-EGFP/B3-iso were considered to over-express plexin-B3 full-length protein  
 120
Figure 22. Examination of the 
expression of plexin-B3 recombinant 
proteins in transfected OLN-93. The 
expression of plexin-B3 and plexin-B3 
∆CD recombinant proteins in OLN-93 
cells transfected with pIRES2-EGFP/ 
B3-iso or pIRES2-EGFP/B3-iso-∆CD 
-EGFP were analyzed by Western blot 
with anti-HA antibody (1:250) 
respectively.   





while the EGFP positive OLN-93 cells transfected with pIRES2-EGFP/B3-iso-∆CD- 
EGFP were considered to express the truncated form of plexin-B3 protein. These 
bicistronic expression constructs therefore facilitate identification of OLN-93 cells 
that expressed the full-length or truncated plexin-B3 proteins. 
When OLN-93 transfected with the empty pIRES2-EGFP vector were subjected 
to oligomerized Sema5A-Fc stimulation, outgrowth and branching of cellular 
processes were induced in a similar pattern to wild-type OLN-93 cells (Fig. 23A, 
24A), Fc conditioned medium showed no effect on outgrowth and branching of 
cellular processes. These findings suggested that transfection had no significant effect 
on the behavior of OLN-93 in response to Sema5A. The promoting effect of 
Sema5A-Fc conditioned medium on cellular process outgrowth and branching was 
abolished in OLN-93 cells transfected with the dominant negative construct 
pIRES2-EGFP/B3- iso-∆CD-EGFP (Fig. 23B, 24B). No significant increase of cells 
with multipolar or branched-process morphology was found in plexin-B3 
∆CD-expressing OLN-93 cells upon Sema5A-Fc conditioned medium stimulation, 
and the percentages were similar between Sema5A-Fc and Fc treated transfected cells 
(Fig. 23B, 24B).  
When OLN-93 cells were transfected with plexin-B3 and treated with 
oligomerized Sema5A-Fc conditioned medium, the percentage of cells showing 
process outgrowth and branching in cultures was significantly higher than that upon 
Fc control treatment (Fig. 23C and 24C). The effect reached maximum at 18 hours 
after Sema5A-Fc treatment. This percentage was also significantly higher than that in 
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OLN-93 cells transfected with EGFP control. With time increasing, the percentage of 
cells showing multipolar or branched-process morphology decreased gradually to a 
similar level to that of plexin-B3 over-expressing cells treated with Fc conditioned 
medium. These results demonstrated that plexin-B3 over-expression potentiated the 
promoting effect of Sema5A on cellular process outgrowth and branching of OLN-93 
while blocking of plexin-B3 signaling by dominant negative manner inhibited 
Sema5A-induced promoting effect. The results revealed that plexin-B3 is the receptor 
that mediates the promoting effect of Sema5A on cellular process outgrowth and 
branching in OLN-93 cells. 
  
3.5.4 Cellular process outgrowth and branching in OLN-93 induced by Sema5A 
involves Cdc42 
Rho family GTPases play an essential role in the control of cellular morphology. 
Recent research on signaling from Fyn to Rho family GTPase suggests that RhoA, 
Cdc42/Rac1 regulate cell shape changes associated with oligodendrocyte 
differentiation: RhoA and Cdc42/Rac1 exhibit opposing effects on oligodendrocyte 
morphologic complexity, possibly through the regulation of microtubule network in 
cellular process (Liang et al., 2004). 
To assess the contribution of Rho family GTPase members Cdc42 and Rac1 to 
the morphologic alterations of OLN-93 cells upon Sema5A stimulation, the activities 
of these two GTPases in OLN-93 were measured by GTPase activation assay. Taking 
advantage of the fact that Cdc42 and Rac1 in their GTP-bound states interact  
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Figure 23. The effect of Sema5A on OLN-93 is mediated by plexin-B3. 
OLN-93 cells were transfected with pIRES2-EGFP/B3-iso or pIRES2-EGFP/B3-iso 
-∆CD-EGFP constructs, and then incubated with Sema5A-Fc or Fc conditioned 
medium. pIRES2-EGFP transfected OLN-93 cells served as a control. The 
morphologic appearance of EGFP positive OLN-93 cells was documented at the each 
time points indicated. Representative morphology of transfected OLN-93 cells 
expressing EGFP (A), plexin-B3 ∆CD (B) and over-expressing plexin-B3 (C) upon 
conditioned medium treatment for 18 hours was documented under both fluorescence 




























































































Figure 24. Quantitative analysis of the effect of Sema5A on OLN-93 
over-expressing plexin-B3 or plexin-B3 ∆CD. Quantitation of the morphology 
complexity of OLN-93 based on cell complexity. More than 60 EGFP positive 
OLN-93 cells expressing vector control (A), plexin-B3 ∆CD (B) or plexin-B3 (C) 
were blindly selected and assigned to one of three categories of complexity: bipolar, 
multipolar or branched-process and spreading. The percentage of OLN-93 cells with 
multipolar and branching morphology was calculated, and subjected to paired t test 
analysis, and the differences between Sema5A-Fc and Fc were deemed statistically 








specifically with PAK (p21-activated kinase), a GST fusion protein containing the 
PBD (PAK binding domain) was generated and incubated with cell lysate prepared 
from OLN-93 treated with oligomerized Sema5A-Fc or Fc conditioned medium for 
various duration. The amount of Cdc42-GTP and Rac1-GTP bound to the GST-PAK1 
fusion protein was analyzed by Western blot using anti-Cdc42 (1:500) and anti-Rac1 
(1:500) antibodies respectively. As depicted in Fig. 25A, the activity of Cdc42 in 
OLN-93 remained unchanged upon stimulation by oligomerized Sema5A-Fc 
conditioned medium for 6 hours, and then increased at 12 hours post-treatment. The 
activity of Cdc42 reached maximum at 18-28 hours, after which it decreased 
gradually to basal level. Meanwhile, a reduction of Cdc42 activity in OLN-93 cells 
upon Fc conditioned medium treatment was observed. The reduction of activity of 
Cdc42-GTP possibly results from the usage of serum-free medium, which can reduce 
activity of Rho GTPases into basal level. As for Rac1 (Fig. 25B), the activities 
remained stable for both Sema5A-Fc and Fc treatment until 48 hours. At 48 hours, the 
activity of Rac1-GTP remained unchanged in OLN-93 cells upon Sema5A-Fc 
conditioned medium treatment but decreased in Fc conditioned medium-treated 
OLN-93 cells. The results suggested that treatment of OLN-93 with Sema5A-Fc 
conditioned medium upregulated the activity of Cdc42 but had no significant effect on 
the activity of Rac1, and this alteration of Cdc42 activity might be involved in 

















































Figure 25. Effects of Sema5A on the activity of Cdc42 and Rac1 in OLN-93 cells. 
(A), Cell lysates from OLN-93 cells treated with Sema5A-Fc or Fc conditioned 
medium harvested at the time indicated were incubated with a GST-fusion protein of 
PAK-binding domain to pull-down the GTP-bound form of Cdc42 and Rac1. The 
amount of active Cdc42 and Rac1 in pull-down assays was determined by Western 
blot with anti-Cdc42 (1:500) and anti-Rac1 (1:500) antibody respectively. (B), 
Relative activities of Cdc42 and Rac1 in OLN-93 cell lysate were determined by 
normalizing the intensity of target bands against the intensity of GAPDH band in 
whole cell lysate at the corresponding time and then comparing with the basal 
activities at the time 0 control. 
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3.5.5 CNPase activity in OLN-93 cells remains stable upon Sema5A stimulation 
The process of oligodendrocyte differentiation from OPCs to mature 
myelin-forming oligodendrocyte is strictly regulated and characterized by the 
expression of specific proteins and lipids. CNP (2’, 3’-cyclic nucleotide 
3’-phosphodiesterase) is a myelin protein that is highly expressed in oligodendrocytes. 
During development, CNP expression is highly upregulated in premyelinating 
oligodendrocytes before the commencement of myelination and maintained 
throughout life (Lee et al., 2005). As for OLN-93 cells, elimination of serum from 
culture for 2-3 days would increase CNP expression without significant alteration in 
the morphological appearance of OLN-93 cells, suggesting CNP can be used as a 
differentiation marker for the initial stage of OLN-93 maturation (van Meeteren et al., 
2005). Furthermore, CNP promotes process outgrowth and arborization of primary 
oligodendrocyte by its microtubule assembly activity (Lee et al., 2005). 
To examine the mechanism underlying Sema5A-induced morphological 
differentiation of OLN-93, OLN-93 cell acclimated to serum-free medium was 
cultured in oligomerized Sema5A conditioned medium for up to 48 hours. At 
pre-determined time points, OLN-93 cells treated with either Sema5A-Fc or Fc 
conditioned medium were harvested and lysed. The expression of CNP in whole cell 
lysate was examined by Western blot. The relative alteration of CNP expression was 
revealed by normalizing band intensity of CNP with GAPDH. Surprisingly, we found 
that Sema5A did not upregulate CNP expression in OLN-93 cells after incubation 
with Sema5A-Fc conditioned medium for the times indicated as compared to Fc 
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Figure 26. Effect of Sema5A on CNP expression in OLN-93 cells. (A), The CNP 
expression in cell lysates from OLN-93 treated with Sema5A-Fc or Fc conditioned 
medium harvested from the time indicated was analyzed by Western blot with 
anti-CNP antibody (1:1000). GAPDH served as house keeping gene control for 
normalization of protein loading. (B), OLN-93 cells plated on gelatine-coated 
coverslips were applied with Sema5A-Fc (left panel) or Fc (right panel) conditioned 
medium and further incubated for 6 hours. OLN-93 cells were then stained with 
anti-CNP antibody (green, 1:200) and DAPI (blue). Photos (e, f) are high 
magnification views of cells in rectangles in the photos (c, d). The morphology of cells 
under bright field was shown in a, b. Scale bars = 50 µm. 
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conditioned medium (Fig. 26A). Interestingly, redistribution of CNP in OLN-93 was 
observed upon Sema5A stimulation for 6 hours (Fig. 26B). DAPI staining showed the 
location of nucleus. CNP was transported to cellular processes and the edge of cell 
body in response to Sema5A-Fc treatment. This redistribution was absent in OLN-93 
cells treated with Fc control: the expression of CNPase was detected mainly in cytosol. 
These findings are different from the previous results reported by Lee et al., 2005. 
This difference may result from the fact that highly differentiated OLN-93 cells, 
which showed obviously multipolar and branched-process morphology, in response to 
Sema5A treatment only accounted for a small population in culture. Upregulation of 
CNP expression, if any, in these cells would have been diluted and not reflected in 
Western blot analysis. Furthermore, redistribution of CNP in response to Sema5A 
stimulation is possibly involved in Sema5A-induced OLN-93 morphological 
differentiation. Of course, it cannot be excluded that the morphological change of 
OLN-93 upon Sema5A stimulation are reflecting alteration in cytoskeletal 
organization, rather than the differentiation and maturation of OLN-93 cells. To 
further illuminate the function of CNP in OLN-93 cells, extensive research is 
recommended.   
 
3.5.6 Summary of results 
As the ligand of plexin-B3, the effect of Sema5A-Fc on OLN-93 cells, which has 
endogenous expression of plexin-B3, was investigated. Results demonstrated that 
Sema5A-Fc inhibited OLN-93 cell migration. Sema5A-Fc also promoted cellular 
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process outgrowth and branching of OLN-93 cells. This promoting effect of 
Sema5A-Fc was mediated by plexin-B3, which was revealed by over-expression and 
dominant negative approaches. The downstream signaling of plexin-B3 upon 
Sema5A-Fc stimulation in OLN-93 cells was examined further. Cdc42 activity in 
OLN-93 cells was upregulated upon Sema5A-Fc stimulation compared with Fc 
control while Rac1 activity remained stable. As a differentiation marker for 
oligodendrocyte, although the expression level was unchanged upon Sema5A-Fc 
treatment, redistribution of CNP in OLN-93 cells was observed in response to 
Sema5A-Fc but not Fc stimulation. 
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Chapter 4 Discussion 
4.1 Summary of results 
Among the cells lines (OLN-93, N2a, PC 12, HEK293 and NIH3T3) examined, 
endogenous expression of plexin-B3 was found only in oligodendrocyte cell line 
OLN-93, with relatively low expression level. As the interaction partners that form 
receptor complexes with plexin-B3, c-Met and ErbB-2 were also detected in OLN-93 
cells, suggesting their potential functional interactions in this cell. Our studies further 
suggested that the association of c-Met and ErbB-2 with plexin-B3 depended on the 
extracellular domain of plexin-B3. By mapping the interaction region in the 
extracellular domain of plexin-B3, similar interacting pattern is shared by c-Met and 
ErbB-2: these specific interactions were mainly mediated through the sema domain of 
plexin-B3, though IPT domains were also involved. MRS domain of plexin-B3 was 
not necessary for establishing the associations. Our results further revealed that the 
extracellular domain of plexin-B3 interacted directly in a homophilic manner. The 
major homophilic interaction site was mapped to the sema domain, though IPT 
domains also mediated weak binding. To date, Sema5A is the only putative ligand 
identified for plexin-B3. Sema5A specifically interacted with plexin-B3 on the cell 
surface. Sema5A inhibited the migration of OLN-93 cells in transwell assay. Sema5A 
was also shown to promote arborized morphology of OLN-93 cells and stimulate the 
branching of cellular processes. This effect was confirmed to be mediated by 
plexin-B3; dominant negative form of plexin-B3 blocked Sema5A-induced 
morphological differentiation of OLN-93 cells while over-expression of plexin-B3 
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enhanced the effect of Sema5A on OLN-93 cells. As for the downstream signaling, 
stimulation of OLN-93 cells with Sema5A activated the small GTPase Cdc42 but had 
no effect on the activity of Rac1. Interestingly, the distribution but not expression of 
CNP, a differentiation marker for oligodendrocyte, was changed upon Sema5A-Fc 
stimulation.  
 
4.2 The importance of sema domain of plexin-B3 in homophilic and heterophilic 
interaction 
Our results of in vitro binding assays demonstrated that the sema domain of 
plexin-B3 is the essential region that mediates homophilic binding and heterophilic 
interactions with ErbB-2 and c-Met. The IPT domain of plexin-B3 is also involved in 
these interactions specifically though the binding affinity is much weaker.  
The sema domain of plexin is highly conserved between members of the family 
during evolution. Beside plexins, sema domain has also been found in the 
extracellular domain of semaphorins and scatter factor receptor with high homology. 
The well established function of the sema domain is to be the ligand-receptor 
recognition site. Binding of Sema4D to plexin-B1 requires the sema domain of 
plexin-B1 (Tamagnone et al., 1999). Furthermore the sema domain of plexins is 
necessary for the interactions of plexin-A with both class 3 semaphorins and 
neuropilins (Takahashi et al., 1999). However, recent evidence has suggested that the 
sema domain alone is not sufficient for establishing the binding under some 
circumstances. For example, the binding with Sema4D depends on multiple structural 
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determinants in the extracellular domain of plexin-B1: C-terminus is also required and 
sema domain alone is not sufficient to mediate the binding (Tamagnone et al., 1999). 
Both the tail and the sema domain of Sema3A are important for binding to Npn-1, 
although binding to the sema domain is weaker (Huber et al., 2003). The TSPs of 
Sema5A efficiently and specifically bind to plexin-B3 while its sema domain only has 
specific but relatively low binding affinity to plexin-B3 (Artigiani et al., 2004). The 
corresponding inhibitory effect of Sema5A TSPs on DRG neurons was observed, but 
the sema domain of Sema5A does not have similar function unless oligomerized 
firstly (Kantor et al., 2004). Distinct with semaphorins and plexins, the sema domain 
of c-Met receptor is required and sufficient for HGF binding (Kong-Beltran et al., 
2004), indicating there are still differences between the sema domains of 
semaphorin/plexin and scatter factor receptors. 
Another critical role of the sema domain is to mediate dimerization of these 
proteins. Sema4D homodimerizes on the cell surface via sema domain through 
disulfide linkage, functioning in B-cell activation and T-cell priming (Kantor et al., 
2004; Shi et al., 2000). Oligomerization of the sema domain of Sema5A is required 
for its inhibitory function on DRG neurons (Kantor et al., 2004). Our data and 
pervious results (Artigiani et al., 2004) suggested that plexin-B3 establishes 
homophilic binding via the sema domain, inducing cell aggregation and neurite 
outgrowth. The sema domain of c-Met mediates dimerization or homophilic 
interaction of the c-Met receptor in the presence or absence of its ligand HGF 
(Kong-Beltran et al., 2004). c-Met over-expression is a common event in human 
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cancer and may determine ligand-independent receptor activation. 
Semaphorins/plexins has also been described in cancers and invasive metastases, 
tempting speculation that over-expression of these receptors induced oligomerization 
of plexins or semaphorins, constitutively activating the downstream signaling.  
Moreover, the sema domain in plexin-A1 was suggested to interact with the rest 
of its extracellular domain, leading to autoinhibition of its intracellular signaling 
(Takahashi and Strittmatter, 2001). Deletion of the sema domain or binding with 
Sema3A/Npn-1 released this autoinhibition.  
To date, the crystal structure of sema domain is mainly obtained from deletion 
mutagenesis and three-dimensional modeling of c-Met, Sema3A and Sema4D. 
Detailed characterization of the sema domain of plexins is still unavailable. These 
structural data are expected to provide information about the structure and 
specification of the sema domain of plexins and give clues for further 
structure/function studies to delineate the various interacting sites of plexins. Former 
analysis revealed that the sema domain folds in a variation of the β propeller topology 
(Gherardi et al., 2004). The β propeller consists of multiple (4-8) four-strand, twisted 
β sheets, formed sequentially and packed face to face around a central axis. The fold 
is stabilized by intersheet hydrophobic contacts and a ‘velcro’-type ring closure 
(Gherardi et al., 2004). From the studies of crystal structure of Sema3A (Antipenko et 
al., 2003) and Sema4D (Love et al., 2003), the putative location for plexin binding on 
semaphorin was suggested to be blade 3 of sema domain, but the precise position of 
the plexin interaction site on the sema domain of semaphorin remains speculative: the 
 137
side of the β propeller in Sema3A and the top surface in Sema4D. The differences 
may account for the binding specificity of semaphorins to their plexin receptors. 
Meanwhile, the sema domain of Sema3A and Sema4D was found to form dimers in 
solution. The dimerization surface is located between three of the intersheet loops 
plus part of the long insertion on the top surface of the β propeller. The fact that the 
residues in the sema domain of Sema4D, which are essential for the dimerization of 
Sema4D, are not conserved in Sema3A (Love et al., 2003) may explain the 
dimerization specificity of Sema4D and Sema3A. However, the binding pattern of 
c-Met sema domain is different from the sema domain of semaphorins (Stamos et al., 
2004). It is implied that the binding of HGF to the bottom surface of the c-Met sema 
domain may leave the top face available for interaction with other molecules, such as 
plexin-B1 and plexin-B3 or c-Met itself, resulting from slight difference of crystal 
structure of the β propeller. The results were confirmed by the evidence from 
functional studies, indicating that ligand-independent c-Met dimers was enhanced by 
HGF binding (Kong-Beltran et al., 2004) .  
 
4.3 The involvement of c-Met and ErbB-2 in plexin-B3 signaling 
Our studies demonstrated that plexin-B3 could associate with both c-Met and 
ErbB-2 through its extracellular domain. Furthermore, these two kinase receptors 
share similar association patterns with plexin-B3: the interactions are mediated mainly 
by the sema domain of plexin-B3 while IPT domains are less involved. Binding of 
Sema5A to plexin-B3 can control the invasive growth by stimulating the tyrosine 
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kinase activity of associated c-Met, which results in the tyrosine phosphorylation of 
both plexin-B3 and c-Met (Artigiani et al., 2004). Plexin-B1 also activates c-Met 
signaling in response to Sema4D binding, resulting in phosphorylation of both 
receptors (Conrotto et al., 2004). Similarly, although no detailed evidence showed the 
involvement of ErbB-2 in Sema5A/plexin-B3 signaling, ErbB-2 is shown to be 
critically involved in Sema4D-induced activation of plexin-B1 and downstream 
signaling processes via RhoA. Activation of plexin-B1 by Sema4D results in 
phosphorylation of both plexin-B1 and ErbB-2, followed by RhoA activation and 
growth cone collapse in primary hippocampal neuron (Swiercz et al., 2004). As 
plexin-B family members interact with c-Met or ErbB-2 in a ligand-independent 
manner, it is conceivable that semaphorin-induced clustering of plexin-B family 
members results in the formation of plexin-B/c-Met or plexin-B/ErbB-2 
heterooligomers, which then allow c-Met or ErbB-2 to dimerize and to become 
activated. Activation of c-Met or ErbB-2 induces autophosphorylation and 
phosphorylation of plexin-B, stimulating downstream signaling. This hypothesis is 
proved by the fact that EGF can inhibit Sema4D-induced plexin-B1 activation in a 
concentration-dependent manner by sequestering ErbB-2 with EGF-bound ErbB-3, 
making it unavailable for plexin-B1 (Swiercz et al., 2004).  
Interestingly, the relative contribution of c-Met and ErbB-2 to plexin-B-mediated 
effects may be distinct. The involvement of c-Met is cell specific. Sema5A-induced 
invasive growth of endothelial cells is mediated by plexin-B3 and requires c-Met as 
association partner with plexin-B3 (Artigiani et al., 2004). In developing hippocampal 
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neuron, c-Met is required for Sema4D/plexin-B1 signaling: dominant negative form 
of c-Met blocks Sema4D-induced growth cone collapse (Swiercz et al., 2004). 
However, Sema5A can induce cellular collapse of NIH3T3 fibroblast cells through 
plexin-B3 signaling independent of c-Met (Artigiani et al., 2004) and 
Sema4D-induced plexin-B1/RhoGEF activation does not necessarily require c-Met in 
HEK293 cells endogenous expressing c-Met and exogenous expressing 
plexin-B1/RhoGEF (Swiercz et al., 2004). According to these observations, it is 
proposed plexin-B family can elicit two distinct signaling pathways; one depends on 
plexin-B and its downstream effectors such as RhoGEF and Rho small GTPase, to 
lead to cellular collapse; and another requires the association of plexin-B with c-Met 
to trigger tyrosine activity, leading to invasive growth.  
For ErbB-2, although the binding of plexin-B family member with their 
semaphorin ligands is independent of ErbB-2, inhibition of ErbB-2-mediated 
phosphorylation of plexin-B1 blocks Sema4D-induced RhoA activation in both 
HEK293 cells and developing hippocampal neurons (Swiercz et al., 2004). 
Furthermore, dominant negative form of ErbB-2 blocks Sema4D-induced collapse of 
axonal growth cones in primary hippocampal neurons, suggesting ErbB-2 is required 
in plexin-B signaling in both fibroblasts and hippocampal neurons. These facts 
collectively prompted us to speculate that, although c-Met and ErbB-2 share similar 
interaction patterns with plexin-B3 and may underlie the similar activation manners, 
c-Met and ErbB-2 may play different roles in activation of plexin-B family members 
and downstream signaling. However, because only a limit number of cell lines and 
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primary cells were tested for the involvement of ErbB-2 in plexin signaling, one can 
still not get a conclusion that the requirement of ErbB-2 in plexin-B signaling is a 
general mechanism while c-Met is cell-specific unless further experiments are 
performed. 
Actually, c-Met and ErbB-2 are essential for the development of oligodendrocyte. 
c-Met is shown to function in the early stage of oligodendrocyte development. 
Activation of c-Met signaling stimulates OPCs proliferation and migration by 
influencing OPCs cytoskeleton organization (Yan and Rivkees, 2002). Although both 
c-Met and plexins have important role in the migration and development of 
oligodendrocyte, whether c-Met has functional relationship with plexin-B3 in 
oligodendrocyte development in vivo still needs to be elucidated. ErbB-2 is critical for 
prooligodendroblasts to differentiate into GalC+ immature oligodendrocytes (Kim et 
al., 2003; Park et al., 2001). ErbB-2 functions to promote the transition of 
prooligodendroblast to immature oligodendrocyte by controlling the exit of cell cycle 
and transducing a terminal differentiation signal. This temporal effect of ErbB-2 is 
very similar to the morphological differentiation-promoting effect of Sema5A on 
OLN-93 cells mediated by plexin-B3. As OLN-93 cells represent an oligodendroglia 
cell line resembling between pro-oligodendrocyte and immature oligodendrocyte, the 
signaling of ErbB-2, associated with plexin-B3, may be activated by Sema5A, 
stimulating the differentiation of OLN-93 cells. More experiments will be needed to 
examine this hypothesis. For example, the function of ErbB-2 can be blocked by 
dominant negative approach, downregulation of its expression using siRNA or by its 
 141
specific inhibitors. ErbB-2 would be functionally related to Sema5A/plexin-B3 
signaling in oligodendrocyte differentiation if blocking ErbB-2 signaling has similar 
effect to inhibition of plexin-B3 signaling on oligodendrocyte differentiation upon 
Sema5A-Fc stimulation.                                                                 
 
4.4 Homophilic trans interaction of Plexin-B3 
By GST pull-down using purified proteins, we demonstrated direct homophilic 
interaction of the extracellular domain of plexin-B3, without any intermediate 
proteins. The interaction region was further pinpointed to the C-terminal side of the 
sema domain of plexin-B3. The N-terminal side of sema domain is possibly left and 
available for the interaction with ligands or interacting partners. For plexins, 
homophilic interaction in trans has been first described dependent on the extracellular 
domain of plexin in Xenopus (Ohta et al., 1995). Plexin-B3 can mediate homophilic 
trans-interaction, resulting in cell aggregation and neurite outgrowth while dominant 
negative form of plexin-B3 with truncated cytoplasmic domain did not inhibit 
homophilic binding-induced cell adhesion (Hartwig et al., 2005). The similar 
homophilic interaction was observed between the extracellular domain of plexin-B2, 
which can induce cell aggregation and neurite outgrowth as well (Hartwig et al., 2005; 
Ohta et al., 1995). Homophilic interaction of various transmembrane proteins, 
including molecules involved primarily in repulsion, has been implicated to be 
common mechanism in stimulation of neurite outgrowth. For example, as highly 
conserved guidance cue, slit signals through Roundabout (ROBO) receptor, 
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controlling midline crossing of axons by inducing growth cone repulsion. The 
extracellular domains of Robo can also establish homophilic adhesion and promote 
neurite outgrowth, indicating a possible role of ROBO receptor in axon selective axon 
fasciculation (Long et al., 2004). Therefore, it is hypothesized that homophilic 
interaction of plexin-B3 possibly induces a currently non-identified mechanism that 
induces cell-cell adhesion, leading to neurite outgrowth of neuron expressing 
endogenous plexin-B3. Furthermore, the endogenous expression of both Sema5A and 
plexin-B3 has also been identified in oligodendrocyte, but their functions in 
oligodendrocyte are still unknown. Both homophilic and heterophilic interactions of 
plexin-B3 may coexist in vivo. One possible function of plexin-B3 is that cell-cell 
adhesion through homophilic trans-interaction of plexin-B3, similar to that in neuron, 
may influence the process outgrowth of oligodendrocytes while oligodendrocytes may 
regulate its migration and differentiation by heterophilic Sema5A-plexin-B3 
interaction. Further analyses are necessary to clarify the roles of the homophilic 
interaction of plexin-B3 in CNS. Thus, plexin-B3 may be a multifunctional receptor 
that induces growth cone collapse in neuron, leads to cellular collapse and inhibition 
of integrin-based adhesion in non-neural cells, leads to invasive growth associated 
with c-Met after the binding of its ligand and stimulates neurite outgrowth through 
homophilic interaction.   
 
4.5 Effects of Sema5A on OLN-93 migration and morphological differentiation 
After originating at specific regions of ventricular or subventricular domains 
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close to the ventral midline of the developing CNS, oligodendrocyte precursor cells 
migrate significant distances to reach their axonal targets and populate the nascent 
white matter. In white matter, they lose the ability of migration and start to 
differentiate to the myelinated mature oligodendrocytes. Our studies on OLN-93 
firstly demonstrated that Sema5A inhibits the migration of OLN-93 cells, most likely 
through its functional receptor plexin-B3. Recent evidence has suggested that 
semaphorins influence the migration of OPCs and alter their trajectory of migration; 
however, the results vary. Evidence has been presented that Sema3A repels OPCs 
migrating from explants of embryonic mouse optic nerve (Spassky et al., 2002). 
Consistent with a repellent role of soluble Sema3A, substrate strips studies showed 
that OPCs derived from neonatal rat brain avoid the area coated with Sema3A, 3B, 3C 
and 3F (Cohen et al., 2003). In contrast, Sema3F attracts OPCs migration from optic 
nerve explants (Spassky et al., 2002). Another experiment suggested that soluble 
Sema3A has no effect on OPCs migration from explants of neonatal rat optic nerve 
(Sugimoto et al., 2001). The contradiction may arise from origin, ages and species of 
the tissues, and experimental oligodendrocytes for explants or isolated cells. The 
evidence demonstrates that semaphorins and their receptor plexins are indeed 
involved in the migration of oligodendrocyte. Beside oligodendrocyte, semaphorins 
exhibit their influence on the migration of neuron and nonneurol cells. The treatment 
of plexin-B3-expressing fibroblasts with Sema5A also led to inhibition of 
integrin-based adhesion, which is suggested to be the primary process of cell 
migration (Artigiani et al., 2004). Sema4D can inhibit both cell adhesion and cell 
 144
migration by regulating integrin activity through plexin-B1-mediated R-Ras activity 
(Oinuma et al., 2006). Furthermore, Sema3A have critical role in regulating 
endothelial cell migration and angiogenesis, as well as in the topographic congruence 
of nerves. Furthermore, semaphorins regulate epithelial cell migration and 
morphogenesis and leukocyte migration (Delaire et al., 2001; Hartwig et al., 2005). 
The contribution of semaphorins and their receptor plexins to OPCs guidance in vivo 
is currently not clear and more investigation will be needed to reveal further relevant 
functional roles.  
αvβ1 integrin is expressed by OPCs and bind to fibronectin and vitronectin, 
which are presented in the extracellular matrix of developing white matter tracts 
during development. OPCs migration requires integrin expression; OPCs migration 
was blocked by inhibition of αv or β1 integrin functions (Milner et al., 1996). 
Interestingly, loss of αvβ1 integrin expression correlates with reduced motility when 
oligodendrocytes mature. Recent studies suggested that activation of plexin-B1 by 
Sema4D suppressed the integrin-dependent R-Ras activation through its R-Ras GAP 
domain, leading to inhibition of integrin-dependent cell migration (Oinuma et al., 
2006). The role of integrin in the Sema5A-induced inhibition of OLN-93 migration 
was investigated. Fibronectin promoted the migration of OLN-93 cells in an 
integrin-dependent manner, but the effect was not significant. This migration 
promoting effect of integrin was blocked by Sema5A treatment. All these results 
demonstrate that R-Ras GAP activity of the cytoplasmic domain of plexin-B3, which 
is supposed to activate R-Ras GTPase and be critical for integrin activation, has 
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limited influence in Sema5A-induced inhibition of OLN-93 migration. As OLN-93 is 
a permanent oligodendroglia cell line, the role of integrin in the migration and 
development of primary OPCs in vitro and further in vivo is still to be investigated. 
 
4.5.1 The mechanistic role of Sema5A/plexin-B3 in morphological differentiation 
and migration in OLN-93 
OLN-93 cells in their morphological features and their antigenic properties 
resemble 5- to 10-day-old (postnatal time) cultured rat brain oligodendrocytes. In their 
morphological features they resemble bipolar O-2A-progenitor cells 
(Richter-Landsberg and Heinrich, 1996). After induced by IGF-1 or cultured under 
reduced serum conditions on poly-L-lysine-coated culture dishes, OLN-93 cells start 
to differentiate to immature oligodendrocyte with more arborized cell morphology. 
These morphological changes are corresponding to the differentiation of OLN-93 
cells, which were confirmed by analyzing differentiation markers on OLN-93 cells 
(van Meeteren et al., 2005). These suggested the correlation between morphological 
appearance and differentiation of OLN-93 cells.  
Sema5A promotes the outgrowth and branching of cellular processes of OLN-93, 
leading to morphological differentiation of OLN-93 from bipolar to multiple-process 
differentiated state. This promoting effect of Sema5A is mediated by plexin-B3, as 
revealed by over-expression and dominant negative approaches. The morphology of 
OLN-93 was altered by Sema5A stimulation. However, Sema5A seems to promote 
but not trigger morphological differentiation of OLN-93 cells because the increase in 
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percentage of OLN-93 cells with ramifying cellular processes and branching in 
response to Sema5A stimulation was relative low in culture and occurred only in 
serum-free conditioned medium. 
Recent studies provided important insights into microtubule organization in 
oligodendrocyte. Microtubule of oligodendrocyte contributes to its specialized 
morphology and myelinating function. Microtubule and microfilament reorganization 
coordinate during process outgrowth and branch formation (Song et al., 2001). 
However, the molecular mechanisms that mediate process outgrowth and branching in 
oligodendrocytes remain poorly understood. 
The well established role of small Rho GTPases is the key regulators of actin 
cytoskeleton, influencing actin remodeling in response to external signals. Small Rho 
GTPases have recently been shown to regulate the dynamics of microtubule and be 
involved in the cross talk between actin and microtubule skeleton. Activation of 
Cdc42 and Rac can promote microtubule dynamics by destabilizing microtubule ends 
through switching microtubule stabilizer X-PAK5 from microtubule to actin (Cau et 
al., 2001). Cdc42 and Rac1 activate p65PAK kinase that inhibits catastrophe 
promoting factor stathmin and therefore stimulate microtubule growth (Daub et al., 
2001). Rac1 also regulates microtubule stabilizer CLASP in cell lamella (Wittmann 
and Waterman-Storer, 2005). RhoA protein can stabilize microtubule through its 
effector mDia (Palazzo et al., 2004). In turn, microtubule growth activates Rac1, 
which in turn induces actin polymerization and lamellipodia formation 
(Waterman-Storer et al., 1999). Furthermore, microtubule depolymerization activates 
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RhoA, which induces cell contraction (Liu et al., 1998). In our experiment, Cdc42 
was found to be activated upon Sema5A stimulation in OLN-93 cells while the 
activity of Rac is unchanged in the similar temporal pattern for Sema5A-induced 
outgrowth and branching of OLN-93 cellular processes. These results suggest that the 
Cdc42-specific signaling may be involved in Sema5A-induced reorganization of 
microtubule in morphological differentiation of OLN-93 cells. Similar results were 
also observed in primary oligodendrocyte culture, suggesting that constitutively 
activated Cdc42 and Rac1 induced morphological differentiation while dominant 
negative forms inhibited oligodendrocyte differentiation (Liang et al., 2004). 
Although Cdc42 and Rac1 share various downstream effectors, such as p65PAK, 
X-PAK5 and IQGAP, to regulate the reorganization of microtubule skeleton, 
Cdc42-specific effector Cdc42 interacting protein 4 (CIP4) binds laterally to 
microtubule and can mediate the association of N-WASP with microtubule. This could 
stabilize microtubule against shortening and further induce outgrowth and branching 
of cellular processes. This hypothesis may explain how Cdc42 but not Rac1 responds 
to Sema5A signaling by increasing its activity. Further studies will be needed to 
investigate the involvement and specificity of Cdc42 in Sema5A/plexin-B3 signaling 
in OLN-93. Introduction of constitutively active form or dominant negative form of 
Cdc42 into OLN-93 will reveal the exact role of Cdc42 involved in 
Sema5A/plexin-B3 signaling. The different functions of Cdc42 and Rac1 have been 
observed in several other systems. For example, p190 RhoGAP, a downstream of 
plexin signaling, has been reported to function in vitro as a GAP for both RhoA and 
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Rac1; the activation of Rac1 is inhibited by over-expression of p190 RhoGAP while 
there is no alteration on the level of active Cdc42 (Liang et al., 2004). In fibroblasts, 
activation of Cdc42 is required and upstream of the activation of Rac1 and then RhoA 
for generation of filopodia (Nobes and Hall, 1995).  
As indicated previously, the migration of OLN-93 was inhibited by Sema5A. 
Cell migration is mainly mediated by reorganization of actin cytoskeleton which is 
regulated by small GTPases family. The fact that the inhibitory effect of Sema5A on 
OLN-93 migration was already significant around 18 hours when the activity of 
Cdc42 just start to increase or just reach maximum prompted us to speculate that 
Cdc42 may not be involved in or not the essential regulator in the early response of 
OLN-93 cells to Sema5A, in this case, the inhibition of cell migration. Although our 
experiment revealed that the activity of Rac1 was unchanged upon Sema5A 
stimulation, one cannot rule out the possibility that the migration of OLN-93 cells 
possibly needs Rac1-specific or RhoA-specific signaling to influence the actin 
cytoskeleton. A possible reason for this is that the earliest time points we took in the 
functional studies may be not suitable to observe the quick alteration of small GTPase 
activation because the activation of Rho small GTPase for regulating actin skeleton 
usually occur fast and last for relative short time. 
CNPase is a prenylated myelin protein that serves as a differentiation marker for 
oligodendrocyte. Furthermore, CNPase is shown to be microtubule interacting protein 
that directs process outgrowth in oligodendrocyte by copolymerizing with tubulin 
(Lee et al., 2005). Our data suggested that Sema5A treatment altered cellular 
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distribution of CNPase to extending processes but did not upregulate the expression, 
implicating that the involvement of CNPase in Sema5A-Fc-induced morphological 
differentiation. 
 
4.5.2 The implication of Sema5A/plexin-B3 interactions in oligodendrocyte 
development 
Although their precursors originate in highly restricted regions at the very early 
stage of development, mature oligodendrocytes are widely distributed in the adult 
CNS. To form myelination for axons, oligodendrocyte precursor cells migrate long 
distance to their final destinations at P0-P4. After that, progenitors settle along the 
whiter matter and then transform into pro-oligodendrocytes. Pro-oligodendrocytes 
would lose their motility but continue to proliferate and finally start to differentiate at 
about P10. Interestingly, the temporal and spatial expression of plexin-B3 mRNA has 
been shown to be coincident with the development of oligodendrocyte, to some extent: 
plexin-B3 is first detectable at P1 in the white matter cells, most likely 
oligodendrocytes. The expression continues to increase and reaches maximum at 
P7-10 until adult stage. In situ hybridization result of Sema5A expression from our 
team showed that its expression increases from P1 and reaches maximum two weeks 
after birth, in a similar pattern to that of plexin-B3. Furthermore, primary 
oligodendrocytes also show specific expression of Sema5A, which is absent in neuron 
and astrocytes during CNS development. In our experiment, OLN-93 cell line was 
used as a useful model for studying oligodendrocyte. OLN-93 cells rapidly proliferate 
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and express antigenic features of maturing oligodendrocyte such as CNPase and MBP, 
suggesting that they have passed the intermediate stage between the OPCs and 
oligodendrocyte. OLN-93 cells represent an oligodendroglia cell line at the later stage 
of differentiation, most likely pro-oligodendrocyte or immature oligodendrocyte, 
though the morphology resembles O-2A progenitor.  All this evidence prompts us to 
speculate that Sema5A/plexin-B3 signaling may be involved in the switching of 
oligodendrocytes from migration to differentiation. We hypothesize that during the 
process in which OPCs stop at white matter and transform to pro-oligodendrocyte, 
both Sema5A and plexin-B3 are upregulated. Sema5A may inhibit the migration of 
OPCs after their arrival at white matter and then promote them to undergo terminal 
differentiation through plexin-B3 signaling. c-Met and/or ErbB-2 associate with 
plexin-B3 and form the receptor complexes to mediate Sema5A-induced effects 
through their individual signaling pathways. Rho small GTPase Cdc42 is activated by 
Sema5A stimulation and its activation promote morphological differentiation of 
oligodendrocytes via reorganization of actin and microtubule skeleton.  
4.5 Future directions 
This study investigated the function of Sema5A/plexin-B3 in the migration and 
differentiation of oligodendrocyte cell line OLN-93. The results showed that Sema5A 
promoted outgrowth and branching of OLN-93 cellular processes through plexin-B3. 
The results reported in this thesis further demonstrated that, the activity of Cdc42, 
possible downstream effectors, was upregulated in OLN-93 upon Sema5A stimulation. 
Our results also revealed that the importance of the sema domain as well as IPT 
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domain in the interaction of plexin-B3 extracellular domain with c-Met and ErbB-2, 
as well as the homophilic interaction between plexin-B3 extracellular domain. 
However, the mechanism of Sema5A/plexin-B3 signaling and the exact role of Rho 
family small GTPase Cdc42 and Rac1 in Sema5A/plexin-B3 downstream signaling 
are unclear. Further investigations are needed to explore downstream signaling 
pathway of Sema5A/plexin-B3 and examine the involvement of Cdc42 in 
Sema5A/plexin-B3 signaling. Furthermore, although all of them have important role 
in regulating the differentiation and migration of oligodendrocyte, little is known 
about the functional relation of plexin-B3 with c-Met and ErbB-2 in these regulation, 




Semaphorins were firstly identified to be the guidance cue in axon guidance 
during development of CNS. Their repellent and attractive effects are mainly 
mediated by their receptor plexins. In this project, we identified the expression of 
plexin-B3, the receptor for Sema5A, in an oligodendroglia cell line OLN-93. Sema5A 
can inhibit the migration of OLN-93 in both integrin-dependent or –independent 
manner. Sema5A also promotes morphological differentiation and this is mediated by 
its receptor plexin-B3 in OLN-93 cells. Sema5A stimulation activates Rho small 
GTPase Cdc42 but has no effect on Rac1. Our studies also revealed the sema domain 
to be main interacting region in plexin-B3 for establishing stable association with 
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c-Met and ErbB-2. Direct homophilic trans interaction of plexin-B3 was identified 
and this interaction mainly depends on the sema domain and IPT domains are shown 
to have role in this direct homophilic interaction. Additional experiments are needed 
to fully elucidate the function of plexin-B3 and the receptor complexes in 
oligodendrocyte and the mechanisms of plexin-B3 signaling. Knowledge of the 
pathways that regulate the activation of plexin-B3 signaling is important to further our 
understanding of the function of semaphorin/plexin family and the mechanisms 
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